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 Abstract 
Many severe infections in humans affect the airways. Different types of pneumonia are major 
causes of morbidity and mortality in patients with various weakening conditions, and often 
ineffective anti-microbial therapies fail to remove the infecting microbes. One of the most severe 
genetic diseases affecting human airways is cystic fibrosis. 
Cystic fibrosis (CF) patients suffer from a genetic defect that influences the salt transport over 
the cell membranes. Due to this effect, the mucus layer becomes very viscous as the defect in salt 
transport inhibit diffusion of and establishment of the important airway surface liquid (ASL). A direct 
consequence of the impaired ASL is the impairment of the mucocilliary clearance mechanisms. This 
results in frequent infections in the airways of CF patients, with the risk of pneumonia. Since bacteria 
infect the lungs of these patients in large numbers, the immune system tries to eradicate the 
infections, but with reduced success. This is due to the fact that the bacteria reside embedded in 
mucus and are more or less recalcitrant to the attack. Instead, the lung tissue is gradually damaged 
by the ongoing immunological exposure, eventually leading to massive pulmonary deficiency and 
death. 
The classical ways of studying CF related bacterial infections, primarily Pseudomonas aeruginosa, 
are either to use animal models or to grow the bacteria in flow cell systems. The use of animal 
models raises ethical concerns and is costly. Besides, CF related animal models are still not ideal, 
mainly because the immune response differs between man and e.g. mouse, and because the lung 
pathology after infection is very different in animals compared to humans. 
In flow cell based systems the bacteria are allowed to form a biofilm on the surface, as in the 
airways, and their growth is then monitored using confocal microscopy. However, this is not either a 
suitable CF model as the human airways are subdivided into aerobic and anaerobic compartments. 
To investigate the different compartments of the human airways system it is crucial importance 
to construct a microfluidic model system in which the oxygen level can be regulated and the 
migration of cells between individual compartments can be controlled and monitored. Furthermore, 
the special conditions in the CF bronchi need to be mimicked as the thick mucus plug present there 
seems to be another essential factor in the failure of treating infections in CF patients.  Therefore, in 
this work we propose novel microfluidic devices that on one hand can mimic different airway 
environments by controlling the oxygen levels and on the other hand can mimic the 
microenvironment of the cystic fibrosis bronchi. 
  
   
 Résumé 
Mange alvorlige infektioner i mennesket påvirker luftvejene. Forskellige typer af 
lungebetændelse er primære årsager til sygelighed og dødelighed i patienter med forskellige 
svækkende omstændigheder hvor ineffektive anti-mikrobiel terapi slår fejl i bekæmpelsen af de 
inficerende mikrober. En af de mest alvorlige genetiske sygdomme  der påvirker de menneskelig 
luftveje, er cystisk fibrose.  
Cystisk fibrose (CF) patienter lider af en genetisk defekt der påvirker salt transporten over 
cellemembranerne. På grund af denne defekt, bliver slimlaget meget viskøst da den defekte salt 
transport hæmmer diffusion og etableringen af den vigtige overflade associerede overflade væske 
(Airway surface liquid, ASL). En direkte konsekvens af den hæmmede ASL er en hæmning af cilia slim 
transporten.  
Dette resulterer i hyppige infektioner i luftvejene hos CF patienter med risiko for 
lungebetændelse. Eftersom bakterier i hobetal inficerer lungerne hos disse patienter,  forsøger 
immunsystemet at fjerne disse infektioner, dog med begrænset held.  Dette skyldes at bakterierne 
lever indpakket i slimlaget og er mere eller mindre modstandsdygtige overfor immunologiske angreb.  
I stedet bliver lungevævet gradvist ødelagt grundet den kontinuerlige immunologiske påvirkning der  
med tiden fører til den massive lunge defekt og død. 
Den klassiske måde at studere CF relaterede bakterielle infektioner på, primært med 
Pseudomonas aeruginosa, er enten i dyremodeller eller ved dyrkning af bakterierne i flow celle 
systemer. Brug af dyremodeller er omkostningskrævende og fører til etiske betænkeligheder.  Ud 
over dette er CF relaterede dyremodeller stadig ikke idelle, primært fordi de immunologiske 
reaktioner afviger kraftigt mellem menneske og eksempelvis mus og ydermere fordi at lunge 
patologien efter infektioner er meget forskellige i dyr sammenlignet med mennesker.  
I flow celle systemer lader bakterierne sig fæstne og danne biofilm på overfladerne, som i 
luftvejene, og deres vækst kan blive monitoreret ved brug af konfokal mikroskopi.   Dette er dog ikke 
et passende CF model system da de humane luftveje er underinddelt i aerobe og anaerobe grene. 
For at udnersøger de forskellige grene af det humane luftvejs system er det er yderst vigtigt at 
konstruere et mikrofluidt model system hvor oxygen niveauerne kan blive reguleret og migrationen 
af bakterierne mellem den individuelle grene kan blive kontrolleret og monitoreret.  
Ydermere, de specielle omstændigheder i CF bronkierne nødvendiggør efterligning da de viskøse 
slim ansamlinger syntes at være en anden essentiel faktor i de mislykkede forsøg i at behandle 
infektioner i CF patienter.  Af denne årsag foreslår vi en nytænkning indenfor mikrofluide systemer, 
 der på den ene side kan efterligne forskellige luftvejs miljøer ved at kontrollere oxygen niveauer og 
på den anden side kan efterligne de mikromiljøer der eksisterer i bronkier  hos cystisk fibrose 
patienter. 
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3 Introduction 
3.1 Motivation 
Cystic fibrosis (CF) is one of the most spread genetic diseases among European and European-
descendant populations. The disease attacks multiple organs among which, the dysfunction of the 
airways clearance is most severe. So far there is no treatment that can alleviate the effects of this 
disease. CF gradually lowers the quality of life and eventually leads to premature death of a patient 
as a result of the recurrent airways infections and decline in respiratory function of the lungs. Due to 
the development of early diagnostics, the prognosis for the patients and their life expectancy has 
improved over recent years. However, a successful therapy that efficiently can treat the infections 
and stop their recurrence has not yet been realised. There is therefore a need for new therapeutic 
strategies based on improved understanding of the infection cycles and the specific interactions 
between the bacteria and the environment in the host organism. 
The current in vivo models of CF related infections are animal models, among which, the mouse - 
either inbred laboratory mice or transgenic cystic fibrosis mice - are the most widely used. These 
models are far from ideal, mainly because of the differences in immune response and the efficiency 
of airways clearing mechanism between mice and human. Besides, the growing ethical concern of 
using animals for medical research makes it especially important to replace or at least reduce the use 
of animals and move toward the use of better in vitro model systems.  
The present in vitro models are mainly based on flow-cell based systems. These models lack to 
describe the complexity of the different compartments of the human airways as well as the 
interaction between these compartments. Irrespective of the quick advancement in the in vivo and in 
vitro models of the CF airways, there is a need for microfluidic models that better resemble the scale 
and conditions met by invading pathogens. Therefore, an advanced microfluidic cell culture system 
that mimics the environmental conditions in three relevant compartments of the airways, i.e., nasal 
sinus cavities, the conductive zones of trachea, bronchi and bronchioles, and the alveolar aerobic 
zone is required, and was developed during this thesis. 
The ability to provide a high-throughput way of studying differences in metabolism, adaptation 
and genetic variability of bacteria living in the airways compartments with different oxygen tension 
 8 
should allow in the future to develop safer, better and more efficient strategies for treatment of CF 
related infections. 
3.2 Aim of the work 
The primary goal of this project was to develop and apply a novel in vitro microfluidic airways 
model that potentially could replace existing, but insufficient animal models. Using the above 
proposed microfluidic artificial airways model, one can look into the bacterial details in the three 
interconnected compartments, their transmitting interaction and the states of the bacterial 
inhabitants before, during, and after antibiotic treatment. The development of an artificial 
microfluidic model, with particular emphasis on resembling the oxygen microenvironments in the 
different compartments should lead to better understanding of the airways and the interactions 
within the complex lung-airway-nasal sinus system.  
Furthermore, a model of the CF bronchi epithelia covered with a thick mucus layer was needed 
to better understand the hindered diffusion of the antimicrobial agent to the focal point of 
infections. 
3.3 Structure of the thesis 
The content of this thesis is based on the results obtained during the three-year period of the 
author’s Ph.D. studies. The thesis has been divided into three main parts: the biological background 
of CF (chapters 4-5), the microfabrication aspects of developing a microfluidic CF airways model 
(chapter 6-7), and the collection of the core results gathered in the published papers and prepared 
manuscripts (chapter 8). 
Chapter 4 is an introduction to the genetic, physiological and microbiological aspects related to 
CF that needs to be considered and that has led up to the design of the microfluidic CF airways model 
in this thesis. Special attention is put on the known reasons for the common failures in the treatment 
of CF related infections alongside with the hypothesis for the causes of the persistent and recurrent 
bacterial colonisation of the airways. The theories that try to explain the impairment of mucociliary 
clearance as well as the resistance of the P. aeruginosa infections to the treatment of different 
antibiotics are presented. The impact of changes in the oxygen tension in the different 
compartments of the CF airways is emphasized in this chapter. 
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Chapter 5 contains a brief review of the few microfluidics models of different human organs 
reported in recent literature. 
Chapter 6 discusses different ways to control the dissolved oxygen concentration in microfluidic 
devices. The techniques used for measurement of dissolved oxygen at the microscale, with special 
focus on the optical methods are presented in this chapter. 
Chapter 7 describes different aspects of microfabrication of microfluidic systems, and finally 
shows the different solutions pursued in this thesis.  
Chapter 8 contains the collection of original papers and manuscripts.  
Paper I (conference proceeding) presents a novel passive micromixer concept that creates direct 
lamination in a 2D channel. This concept is further described in paper II (full published paper). 
This passive micromixer was further used in the microfluidic airways model described in paper V 
(manuscript). 
Paper III (conference proceeding) reports the work performed towards development of a 
dissolved oxygen gradient generator as part of a microfluidic system that can simulate the 
aerobic and anaerobic conditions in the human airways. This system is further described in paper 
IV (full published paper).  
Paper V (manuscript) contains the description of a modular microfluidic system as a model of the 
CF airways.  
Paper VI (accepted conference proceeding) presents the work towards mimicking the CF bronchi, 
which is followed by Paper VII (manuscript) where this system is described in more detail.  
 
The collection of the papers is followed by chapter 9, that contains some brief conclusions and 
future perspectives of the systems developed in this work. The thesis is concluded by a list of 
references. 
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4 Biological background 
4.1 Human airways 
The human airways consist of at least three independent compartments, the conductive airways 
(the trachea, bronchi and bronchioles), the oxygen exchange compartment also called respiratory 
zone (respiratory bronchioles, alveolar ducts and alveolar sacs), and a third less recognized 
compartment, the paranasal sinuses (maxillary sinuses, frontal sinuses and ethmoid sinuses) (Figure 
1). In the first and the last compartment, the environment is essentially anaerobic or micro-aerobic, 
while the alveoli are highly aerated[1]. Traditionally, the airways are divided into the upper 
respiratory tract (nasal cavity, paranasal sinuses, pharynx) and lower respiratory tract (trachea, 
bronchi, bronchioles and pulmonary alveoli)[2]. 
 
 
Figure 1. The human airways. 
The upper respiratory tract is the home for bacterial flora[3, 4], while the lower respiratory tract 
in healthy persons, usually remains sterile.  
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4.2 Cystic fibrosis 
4.2.1 Mutation in the CFTR gene 
Cystic fibrosis (CF) is a severe genetic multiorgan disease, common in European and European-
descendant populations[5]. A mutation in the Cystic Fibrosis Transmembrane Conductance Regulator 
(CFTR) gene cause dysfunction of the mucosa1[6]. Due to this dysfunction, the secreted mucus is less 
hydrated and therefore much more viscous than in a healthy person. This make the natural 
mechanisms of clearing and renewing of the mucous layer impaired. The epithelia of the exocrine 
pancreas, intestine, hepatobiliary system, male genital tract, exocrine sweat glands and, most 
importantly, the airways are affected by this defect[7]. 
The product of CFTR gene, the CFTR protein, has many roles as an ionic channel and regulator[8].  
The protein plays a main role as the chloride channel and the chloride ions regulator, but it is also 
involved in regulation and inhibition of sodium transport (epithelial sodium channels), regulation of 
ATP channels and regulation of vesicle transport in the cells. The CFTR protein also plays a role in 
acidification of intracellular organelles[9-14]. 
There are more than 1 800 different mutations of CFTR gene[15], but in about 70% of the CF 
cases the mutation is a deletion of three-pairs of nucleotides at position 508 (ΔF508) [16]. These 
three-pairs are coding for phenylalanine[17, 18] and the lack of this amino acid residue results in 
improper folding of the CFTR protein and its quick ubiquitination and degradation[14]. Different CFTR 
gene mutations have been gathered and classified according to its effects by Welsh and Smith[19]. 
4.2.2 Diagnosis of cystic fibrosis 
The final effect of most of the mutations is impaired transport of the chloride ions by the CFTR 
protein. Therefore diagnosis of CF is usually made clinically by measuring of the chloride ions 
concentration in sweat. 
Sweat produced by glands in the dermis contains chloride ions in concentration of approx. 
105 mM and is equal to the concentration of chloride in serum. Sweat is transported from the gland 
to the surface through dermal ducts, where the chloride should be absorbed by the epithelial cells in 
                                                            
1 The membrane lining bodily cavities containing cells that secrete mucus 
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a CFTR-dependent manner (Figure 2). In healthy individuals the chloride concentration in secreted 
sweat is below 40 mM [20]. 
 
 
 
Figure 2. Scheme of the healthy and cystic fibrosis sweat gland[20]. 
A chloride concentration in the sweat above 60 mM, determined at least twice or more by 
quantitative pilocarpine ionophoresis, indicate CF[21]. The need for more than one measurement at 
different occasions arises from the risk of false-positive test results. The temporary increase in the 
chloride concentration in sweat can sometimes occur in the healthy person, especially for older 
adults[20, 22]. 
False-negative sweat test results can occur for patients with CF. There are some CFTR mutations 
(patients homozygous for ΔF508 with additional R553Q mutation in one of the alleles) that masks 
improper chloride channel function[23]. False-negative sweat test results can also occur in 
malnourished patients with pulmonary oedema[24]. Therefore, positive sweat test result should be 
followed by genetic screening. Even the genetic screening, due to the numerous possible mutations 
in CFTR gene, is not always 100% conclusive[20]. 
4.3 The dysfunction of the salt transport in CF epithelia 
The dysfunction of the CFTR protein in conductance and regulation of the chloride transport, 
exemplified for sweat glands (Figure 2), hinder secretion of the fluids by pulmonary epithelial cells. 
This leads to changes in the mucus physical and chemical properties and impairment of the 
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mucociliary clearance mechanism in the airways[25]. There are several theories that try to explain 
this impairment, but two of them seem to be most probable, referred to in literature as ‘high salt’ 
and ‘low salt’ theories[26]. The ‘high salt´ theory assumes that the mucus in CF patients has elevated 
sodium chloride concentration. This phenomenon is explained in the same way as in the case of the 
high chloride concentration in sweat, i.e. a high mucus osmolality deactivates the antimicrobial 
peptides secreted by the epithelia, called defensins. This allows bacteria to successfully colonise the 
airways[27, 28]. 
The ‘low salts theory’ also refers to CFTR proteins, which is involved in control of the sodium and 
chloride ions transport mechanism in airway epithelial cells. In healthy epithelia, CFTR allows the cell 
to reabsorb sodium and secrete chloride ions. A high salt concentration in the mucus, osmotically 
drives the water out from the epithelia and rehydrates the mucus (Figure 3). In CF patients, the CFTR 
protein, acting as a chloride channel, is dysfunctional, and thus hinders the salt transport. This leads 
to high salt concentration in the epithelia and low concentration in the mucus, which stops water 
from rehydrating it[26]. Most of the recent publications assume the ‘low salt’ theory and 
dehydration of the mucus.  
 
Figure 3. Hydration control and salt transport mechanism in airway epithelial cell in healthy individuals and CF patients 
(adopted from [26]). 
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4.4 Mucociliary clearance mechanism in healthy individuals and CF 
patients 
The epithelia of the airways is covered by a layer of airway surface liquid (ASL). This liquid, in 
healthy individual airways, can be further divided into two layers according to the viscosity. The 
lower layer, with low viscosity, embeds the cilia growing out the ciliated epithelial cells. It contains 
mainly water and salts and is about 7 µm thick[29]. This layer is referred to in literature as perciliary 
liquid (PCL). The top layer is more viscous and contains, besides water (approx. 98%), salts 
(approx. 1%) and mucin (approx. 1%)[30]. Mucin is a glycosylated protein secreted in the upper 
respiratory tract and lungs by goblet cells and by Clara cells in the terminal bronchioles[31]. 
These two layers protect the lower respiratory tract from infections. In the healthy person, the 
lower respiratory tract is basically sterile while the upper tract is not, which therefore can be a 
source of infecting germs to the lower tract. The sterility of the lower respiratory tract is maintained 
by the fact that the invading germs adhere to the top viscous mucus layer. This layer is then 
transported up the respiratory tract and is removed either by coughing it out or swallowing. The 
transport of the viscous layer is possible only if the lubricating PCL between the top layer and 
epithelium has low viscosity, implying proper hydration. This transport is facilitated by small cilia 
where each cilium performs a slow movement actuating the flow of the mucus. The linear velocity of 
the mucus is in order of tens of micrometres per second[30]. Therefore, in a healthy person´s airways 
the mucus layer is constantly cleared and renewed by the mucociliary system (Figure 4)[32, 33].  
 
Figure 4. The mucociliary clearance mechanism in healthy individuals and CF patients (adopted from [26] and [29]).  
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4.5 Difference between infection clearance systems in conductive and 
respiratory zones 
The mucociliary clearance mechanism is responsible for keeping the conductive zone of the 
human airways sterile. However, the respiratory zone lacks cilia and submucosal glands and the 
defence system against pathogens works in a different manner than the conductive zone. In order to 
facilitate gas exchange, the barrier between blood and air is very thin in the alveoli. Therefore, the 
immune system has a direct access to the surface of the epithelia in the respiratory zone and can 
efficiently eradicate most of the infections[34]. 
This difference between the conductive and respiratory zones also affects the treatment of an 
infection. The antibiotics administered intravenously or orally have better effects on treating the 
infections in the respiratory zone while being much less effective on the pathogens residing in 
conductive zone[35]. On the other hand, the nebulization of antibiotics allows to affect pathogens in 
the conductive zone in a much more efficient way than in the respiratory zone[36-38]. 
4.6 Infections associated with cystic fibrosis 
Due to the impairment of the mucociliary clearance mechanism, CF patients are afflicted with 
frequent airways infections. The source of the infections is the upper respiratory tract. In healthy 
airways, the sterility of the lower respiratory tract is maintained by the fact that the invading germs 
adhere to the thin mucus layer, which is constantly cleared and renewed by the mucociliary 
system[32]. The mucus in the CF patients airways is very thick and viscous and the patient cannot 
clear the tracts[30]. 
The most common bacteria that colonise the airways of CF infants are Haemophilus influenzae 
and Staphylococcus aureus[8]. The simultaneous infection with both of these pathogens is not 
uncommon. In older patients (3 years old or more) Pseudomonas aeruginosa becomes the 
predominant pathogen[39-41]. Approximately 70% to 80% of CF patients are infected with this 
bacteria before reaching adolescence. This can be a result of the fact that P. aeruginosa is a common 
bacteria in the environment[42], which is spotted as an opportunistic bacteria in humans. Up to 20% 
of CF patients have their gastrointestinal tracts infected with P. aeruginosa[43]. This bacteria is also 
responsible for recurrent infections[44]. 
 17 
4.7 Biofilm formation of P. aeruginosa in CF lungs 
Biofilms are communities of bacteria living in a complex extracellular matrix where cells are 
attached to each other or to a surface. This matrix consist mainly (approx. 75-89% of the 
composition) of proteins, exopolysaccharides[45] and additionally nucleic acids, lipids and 
phospholipids[46, 47]. Bacterial biofilms are very common in all kinds of environments including the 
human body[48], where the most commonly known is dental plaque[49].   
The formation of a biofilm is probably due to the response against unfavourable conditions[50]. 
The first step of the biofilm formation is an initial attachment of a previously planktonic cell2 (Figure 
5 A) to the surface. If the cell does not leave the surface nor is cleared from it, the cell becomes 
irreversibly attached (Figure 5 B). The next generations of the cell stay on the surface. Bacteria will 
start to secrete the matrix, making the surface even more attractive to the following cells and the 
biofilm will grow and mature (Figure 5 C and D). If the conditions for the growth will aggravate, the 
biofilm will start to dissolve and the cells become planktonic once again in order to find a spot with 
more suitable conditions (Figure 5 E)[51]. 
 
 
Figure 5. Biofilm formation and dissolution: (A) bacteria in the planktonic state, (B) attachment to the surface (C) 
biofilm growth, (D) mature biofilm, and (E) dissolution of the biofilm. 
P. aeruginosa, as well as number of other bacterial and fungal species, can form biofilms. 
P. aeruginosa biofilms were found in the sputum[52, 53], freshly excised lung sections[50, 54] as well 
as in the post mortem explanted CF lungs[55]. However there is no consensus if the main form of 
P. aeruginosa exists in CF lungs as a biofilm[40].  
 
 
                                                            
2 Cell which can float or swim in the aqueous media 
A B C D E 
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4.8 Antibiotic resistance and tolerance of CF infections 
Bacterial airway infections in patients with a normal mucosa are relatively easy to treat with 
antibiotics. This is unfortunately not the case for CF patients and the myriad of infections they 
acquire during their lifetime leave each patient with a high need for recurrent antibiotic treatments. 
This is a multifactorial phenomenon and a lot of theories that try to explain it have recently been 
published[56-59]. 
4.8.1 Antibiotic resistance and antibiotic tolerance 
Antibiotic resistance needs to be distinguished from antibiotic tolerance. Antibiotic tolerance, 
unlike resistance, is not heritable by the tolerant cell progeny. It is rather connected to its decreased 
metabolic activity or the surrounding of the cells. Tolerant cells can still be non-resistant to antibiotic 
when its metabolic activity increases or its surrounding will change (Figure 6)[60]. 
Bacterial biofilms are much more tolerant to antibiotic treatment than planktonic cells. The 
minimum inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) for the 
bacterial biofilms, especially for one cultivated for long time,  can be 1000 times higher than for the 
planktonic form or the newly formed biofilm of the same species[50]. 
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Figure 6. Antibiotic resistance and antibiotic tolerance. 
4.8.2 Antibiotic diffusion through bacterial biofilm 
The most obvious reason for a treatment failure in the CF airways is the hindered diffusion of the 
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obstructed if the agent needs to diffuse through the biofilm matrix[61, 62]. However, according to 
recent findings, the main reason may reside in limited oxygen availability in some parts of the 
airways[57, 63]. These highly different oxygen environments are due to the human physiology of the 
airways and furthermore endured by the oxygen consumption of epithelial and immune cells in the 
local surroundings. 
4.8.3 Influence of oxygen tension on bacterial metabolism 
As P. aeruginosa infections are almost inescapable in CF patients, especially in older patients, this  
makes P. aeruginosa an important organism for studies of “oxygen” phenomena[40]. 
P. aeruginosa is a facultative anaerobic bacteria[64] with reduced growth rate (paper IV) and 
metabolic activity[57] at low oxygen levels. Antibiotics such as tobramycin, ciprofloxacin, and 
tetracycline preferentially kill the physiologically active bacteria living at high oxygen levels (aerobic 
environment), while colistin is more effective on the physiologically inactive bacteria growing in 
anaerobic environment[65-67]. 
In the densely packed biofilm, the cells living at the biofilm surface have considerably different 
nutrients and oxygen accessibility than the cells inside the biofilm[57]. This affects the metabolism 
and growth of cells. The metabolically active and fast dividing cells at the biofilm surface are more 
susceptible for exposure to tobramycin, ciprofloxacin and tetracycline, while the cells inside the 
biofilm remain mostly unaffected. This renders the standard antibiotic monotherapy not suitable for 
biofilm infections. The mixture of at least two antibiotics that can target cells of different metabolic 
activity, e.g. colistin and ciprofloxacin, is usually needed to treat the infections in CF patients[68, 69]. 
4.8.4 Persister cells 
Irrespectively of the environmental reasons, some bacterial cells are growing very slowly or even 
at some point cease to divide. This usually very small fraction of cells are called persisters[70-72] and 
are considered as dormant cells. Since the metabolism of these dormant cells is very slow the 
antibiotics that kill the metabolically active cells will not be able to clear the former. However, even 
some of the antibiotics that affects slow-dividing cells will not be effective for clearing the persister 
cells[73].  
The exact way that leads a cell to its dormant state is not yet fully understood, but it seems to be 
connected with the toxin/antitoxin system present in most bacteria[74] [75-77]. This mechanism may 
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be connected with different functions of the bacterial cells, e.g. reaction to stress, maintenance of 
plasmids, programmed cell death and even biofilm formation[78-81].  
4.8.5 P. aeruginosa biofilm resistance to antibiotics 
The use of beta-lactams, from which penicillin was the first commonly used antibiotic, has a long 
history. The long time exposure and common overuse of antibiotics in general has allowed bacteria 
to develop specific resistance against them over time. The aggressive antibiotic treatment of CF 
infections has for instance allowed P. aeruginosa to quickly develop very efficient expression of the 
beta-lactam degrading enzyme beta-lactamase[82]. Moreover, the biofilm forming P. aeruginosa can 
secrete this enzyme into the intracellular matrix, making the antibiotics unable to reach the cells 
embedded into the matrix[83]. The use of beta-lactamase inhibitors[84] or beta-lactamase-stable 
antibiotics like meropenem[84] seems to be necessary for treatment of CF related infections with 
P. aeruginosa. 
Some strains of biofilm forming P. aeruginosa have developed a specific antibiotic resistance 
mechanism, which is less active in planktonic cells, the so-called efflux pump[58].  The efflux pump 
can actively remove aminoglycosides such as tobramycin, gentamycin as well as ciproflaxin[85]. 
Another mechanism for P. aeruginosa resistance to tombramycin is the production of perismatic 
glucans which can bind this antibiotic[86]. Tobramycin, in order to be effective, needs to enter the 
cytoplasm and to bind to the 30S and 50S subunit of the bacterial ribosome. If most of the antibiotic 
is bound in the periplasm, much larger doses are needed in order to reach the cytoplasm and 
overcome this resistance mechanism. 
4.8.6 The mucoid and non-mucoid phenotypes of P. aeruginosa in chronic infections of 
CF patience 
The wild type strain of P. aeruginosa is a non-mucoid and is relatively easily treatable with 
antibiotics[87]. However, if the infection by this pathogen is not completely eradicated, the wild type 
non-mucoid strain can mutate into the mucoid strain. The mucus secreted by this strain contains very 
viscous alginate. The mucoid phenotype of P. aeruginosa is very hard and in some cases even 
impossible to treat with antibiotics and the patients can become chronically infected[88-90]. 
Recent findings[91] give hope for the treatment of mucoid P. aeruginosa strain with a mixture of 
nebulized colistin and gentamicin applied twice daily in a long-term manner. However, even this 
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harsh treatment allowed clearance of only 58% of the CF patients infected with the mucoid P. 
aeruginosa strain. 
4.9 Airways damages caused by recurring infections in CF airways 
As was described above, the mucociliary clearance mechanism physically removes pathogens 
from the conductive zone of the human airways and keeps and protects it from infections. The 
impairment of this system in CF patients leads to frequent and persistent infections, which escalates 
the response of the immune system and inflammatory defence mechanisms. These involve increased 
activity of the polymorphonuclear neutrophils 3  (PMN), which secrete reactive oxygen species 
(ROS)[92, 93]. This defence mechanism works well in compartments where the mucus is not present, 
e.g. in the alveolar sacks, however is not very effective in the conductive zone of the CF airways, 
which is covered with very viscous mucus. The concentration of ROS is high at the epithelia and 
brings damage to the tissues, but is not high enough in the mucus to kill the bacteria[34]. This effect 
of the immune system activity is responsible for inducing a mutation in the P. aeruginosa mucA gene, 
which leads to the transformation of the non-mucoid strain into the mucoid one. This mutagenic 
effect is likely due to the increased ROS concentration in the environment of the CF airways[94]. The 
alginate present in the biofilm of the mucoid phenotype protects the bacteria embedded in the 
extracellular matrix from the ROS[95]. Therefore, the mucoid phenotype of P. aeruginosa is not only 
tolerant for antibiotic treatment, but can also resist the immune system. Hence, the mucoid 
phenotype of P. aeruginosa which was not removed by the mucociliary clearance mechanism nor by 
the immune system response in the conductive airways, can now colonise the respiratory zone.  
Recent findings show that the biofilm forming P. aeruginosa can protect themselves not only 
from ROS and antibiotics but also from other defence mechanisms, e.g. from phagocytosis[65]. The 
PMNs cannot reach the bacteria not only because of the physical barrier of extracellular matrix, but 
also because they are actively lysed (Figure 7). The factors that induce PMNs necrosis were identified 
as rhamnolipids, secreted by certain strains of P. aeruginosa[96]. 
                                                            
3 A type of white blood cells 
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Figure 7. The damage in alveolar epithelia caused by the PMNs lysis induced by rhamnolipid expressing P. aeruginosa 
strains.  
The secretion of these rhamnolipids has been connected to a quorum sensing (QS) mechanism, 
which allows bacterial cells to communicate[97]. The high concentration of the QS molecules gives a 
signal to the cells about their number, which controls the expression of virulence factors such as 
proteases, pigments, hemolysins and exotoxins[98]. 
In conclusion, the lysis of PMNs, further secretion of ROS, together with virulence factors lead to 
the escalation of the inflammatory mechanism and further damage to the tissues and impairment of 
the respiratory functions[99]. In the healthy person pulmonary function decline with the rate of 
approx. 1-2% per year[100], while this rate in CF patients is about 4 – 10%[101]. Considering the fact, 
that bacterial infections of CF patients are recurrent and very hard to treat, the damages to the 
tissues are eventually fatal. 
4.10 In vivo models of the lung infections in CF patients 
Animal models have proven to be useful in the study of different diseases, their mechanisms and 
possible treatment therapies. The recent advances in genetic manipulations, e.g. specific gene knock-
outs or transgenic animals, have brought new tools for medical research[102]. A number of different 
animals have been tried as models for chronic infections in CF patients[103]. This includes rats[104-
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106], guinea pigs[107], cats[108] and rhesus monkeys[109, 110]. However the most important animal 
model is today a mouse[111-114].  
The main challenge in using the animal models that are not genetically modified has been to 
overcome their very effective mucociliary clearance mechanism. This was done by introduction of 
bacteria artificially embedded in gel matrix such as agar[111], alginate[104] or gastric mucin[115] or 
by suppressing their immune system[103]. However, the effects of these operations were usually not 
satisfying. The animals were either quickly clearing the infection or dying[116]. 
Mice with a CFTR gene knock-out[117] and, more recently, transgenic mice with differently 
mutated human CFTR[118] has brought a new quality to the research on CF related infections. 
However, the main challenge here is a very high fatality among the animals with a dysfunctional CFTR 
gene. The very low survival rate, which even can be below 5%, is mainly due to intestinal problems 
and not due to the respiratory failure[119]. Besides, the animal models of CF related infections are 
still not ideal, mainly because of the immune response differences of man and e.g. mouse, but also 
because the lung pathology after infection is very different in animals compared to humans[103]. The 
other disadvantage are the relatively high costs and growing concerns about ethical aspect of using 
animal models in research[120].  
4.11 In vitro models of the lung infections in CF patients 
The most commonly used and standardized devices for studying initiation and growth of 
bacterial biofilms are microtitre plates. They are especially useful for high-throughput screening of 
attachment of the bacteria to different substrates and initial response of the biofilms for 
chemotherapy[121, 122]. It is however very difficult to use these plates for long time observation of 
biofilms, even when one can use robots for automated culture media change. 
So far, the most successful in vitro models for studying biofilm formation are different kinds of 
flow cell systems. These systems allow to observe the attachment of bacteria, biofilm formation and 
dissolution of the biofilm while nutrients and metabolites are constantly flowing into and out of the 
system[123]. 
The typical flow cell system is comprised of a culture media container, a multichannel pump, a 
flow cell and a waste container. During the constant flow of culture media, air bubbles can gather in 
the flow chambers and disrupt the biofilm. Therefore the flow cell systems are usually equipped with 
bubble traps (Figure 8)[124]. 
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Figure 8. A flow cell system setup (reprinted with permission from[124]). 
The flow cell systems allow to studying biofilms for an extended period of time, which is usually 
not feasible with biofilm formed in a microtitre well plate or in other standard culture vessels like 
tubes and petri dishes. Together with confocal laser scanning microscopy and specialized software 
for biofilm analysis like COMSTAT, the flow cell systems are powerful tools in studying bacterial 
biofilms[125].  These systems have successfully been used for determining spatial distribution of 
bacteria sensitive for different antibiotics[67, 126-128] as well as for the studying the distribution of 
motile and non-motile strains of P. aeruginosa[129]. The disadvantage of these systems is the quite 
complicated and time consuming assembly and lack of high-throughput capabilities in comparison to 
microtitre well plates[123, 124].  
4.12 Summary 
In most cases, CF patients suffer from infections caused by P. aeruginosa. This species can live in 
aerobic as well as in anaerobic conditions. These different conditions together with the mutagenic 
habitats caused by immunological response of the host make the bacteria highly changeable and 
adaptive to the environment. Together with its ability to form a biofilm, P. aeruginosa is extremely 
hard to eradicate from CF patients airways.  
An antibiotic treatment can eventually seem successful, yet after a few months the very same 
bacteria which were responsible for the infection can reappear, possibly as a result of reinoculation 
from the anaerobic sinus[63, 130]. In this context the sinuses could very well serve as a reservoir for 
‘sinus’ bacteria, which are difficult to treat with antibiotics and can cause the reinfection of 
otherwise cleared patients. P. aeruginosa infections will eventually become chronic and the 
pulmonary function will start to quickly deteriorate leading finally to the patient’s death. 
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Therefore it seems to be crucial to better understand the differences in the metabolism, 
adaptation and genetic variability of bacteria living in the airways compartments with different 
oxygen tension. It is also very important to be able to mimic and observe the different environments 
of the human airways, the effect of infection treatment and the interaction between bacteria and 
tissues at the cellular scale. Thus, the microfluidic systems seems to be particularly useful to perform 
such studies.  
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5 Microfluidic devices as models of human organs 
The use of animal models for studying different diseases and research on new pharmaceutics 
seems to be inescapable at present time[131]. However, there is a very strong pressure from public 
society, particular states and international organizations legislature, as well as from industry to 
replace, reduce and refine the research conducted with the use of animals[132, 133]. This strategy is 
known as the “3 Rs” principle[134, 135]. 
The development in cell culture as models of tissues and entire organs allowed to partially fulfil 
these expectations[136]. The main limitation of these substitutes is the lack of complexity of specific 
interactions between different tissues and organs in living organisms[137]. The recent advancement 
in tissue cultures, especially using microfluidic devices, give hope for overcoming some of these 
limitations[138-141]. 
The advancement in the micro- and nanofabrication and assembly as well as better 
understanding of microfluidics have allowed to develop devices for modelling different tissue organs.  
Thanks to these devices the control over the environment, relations and interactions between the 
cells and tissues at microscale and with high special and temporal resolution can be achieved[142, 
143]. The yet small but fast growing number of the microdevices that can reassemble different and 
even entire organs have been reported. This includes blood vessels[144], bones[145], muscles[146], 
liver[147-150], brain[151], guts[152], kidneys[153, 154], endothelia[155] and blood-brain 
barrier[156]. 
In the field of mimicking the human airways, Huh at al.[157, 158] proposed a microfluidic device 
that can simulate injuries to the airways epithelia done by liquid plug flow. The same group proposed 
recently a model of the vacuoles in the lung[159]. In this work the phagocytosis of planktonic 
Escherichia coli cells by neutrophils on the epithelial surface was shown. 
The silicon microfluidic device capable of exchanging gases form the blood stream has been 
recently shown by Hoganson et al.[160] This microfluidic device may be considered as a first step in 
developing a system for assisting patients with respiratory failure. 
According to the author’s best knowledge the microfluidic model of CF bronchi nor the model of 
different compartments of human airways, which would allow the observation of the influence of the 
microenvironment of these compartments on the development and clearance of bacterial infection, 
has not been reported previously. 
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Therefore, a model system that simulates the three compartments of the human airways is 
postulated (paper III and IV). The three sections of the human airways: the conductive airways 
(trachea, bronchi and bronchioles), which are considered micro-aerobic, the highly aerobic gaseous 
exchange compartments (the alveoli) and the compartments of the paranasal sinuses, which are 
basically anaerobic (Figure 9A), are reproduced in this Microfluidic Airways Model (MAM). It is 
realized by cell culture microchambers with different oxygen levels (Figure 9B). The microchamber 
with atmospheric air oxygenated media (aerobic environment) is connected by an additional channel 
to the microchamber with culture media, saturated below the atmospheric air saturation level 
(micro-aerobic environment). This chamber is consecutively connected to the chamber with 
deoxygenated media (anaerobic environment). The connections between the chambers as well as to 
the outlets can be closed and opened, and the actual oxygen level can be determined by using an 
oxygen probe.  
 
Figure 9. (A) Human airways system, (B) Microfluidic Airways Model (MAM). 
The impairment of mucociliary clearance in CF bronchi seems to play very important role in 
developing chronic infections and reinoculation of the bacteria in the alveoli.  Therefore a model of 
CF bronchi, was also proposed (paper VI and VII). 
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Figure 10. (A) Bronchi of the healthy individual and CF patient. (B) The microfluidic model of CF epithelia. 
The microfluidic model of the CF bronchi consists of two microchannels separated by a 
microporous membrane (Figure 10). The membrane is a support for a hydrogel, which mimics the 
mucus layer in CF bronchi. The hydrogel can, in a similar way as in the mucus layer, be enriched with 
different components like DNA and proteins. The microchannel below the membrane simulates the 
artery, which supplies the nutrient containing media and transport of metabolites. These compounds 
are further supplied to the top channel by diffusion through the membrane and hydrogel. On the top 
part of the hydrogel the bacterial cells can be inoculated and cultured while at the bottom side of the 
membrane, epithelial cells are cultured. The top microchannel is enclosed with a cover slide, which 
allows observation and analysis of the biofilm growth by confocal microscopy.  
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6 Oxygen sensing and control in microfluidic biodevices 
6.1 Oxygen permeability of different materials used for microfabrication of 
biochips 
One of the most commonly used material for fabrication of microdevices used for biology is 
poly(dimethylsiloxane) (PDMS)[161-163]. PDMS is a chemically inert, biocompatible and optically 
transparent polymer[164] that is very commonly used for construction of microdevices[165, 166]. 
The most useful technique for microfabrication in PDMS is casting the not yet cross-slinked polymer 
against a mould. 
These properties make PDMS a popular material for fast prototyping of microdevices particularly 
for cell culture purposes. Furthermore it can be utilised as a component in an active scheme of 
oxygen removal due to its high permeability for gases and vapours.  
This high permeability of PDMS can in some cases be considered as a flaw, especially in 
applications where very small volumetric flows of aqueous media are involved. The high permeability 
to vapour means that the media can evaporate through the PDMS. This effect is particularly 
problematic in microdevices, where the surface to volume ratio is very high[167]. Other 
disadvantages of PDMS is the unspecific absorption of hydrophobic molecules[168]. This is due to the 
very high hydrophobicity of the material itself, connected with high solubility of hydrophobic species 
in loose PDMS chain networks. Moreover, the uncured short PDMS oligomers as well as the platinum 
based curing catalyst can leak out from the bulk of material[169, 170]. The high hydrophobicity also 
implies nonspecific adsorption of proteins to the PDMS surface[171]. 
The polymer of choice, when low gas permeability is required, would be poly(ether ether ketone) 
(PEEK). This material has very low oxygen permeability along with very high chemical and mechanical 
resistance[172], as well as exhibiting excellent biocompatibility[173, 174]. However the high price, 
challenging bonding, and lack of transparency makes it difficult to extensively use this polymer for 
constructing microdevices[175, 176]. Therefore the other thermoplastic polymers such as 
polystyrene (PS)[177], cyclic olefin copolymer (COC)[178], poly(methyl methacrylate) (PMMA)[179-
181] (papers I-IV), polycarbonate (PC)[182] (papers V-VII) are more common in microdevice 
fabrication. These materials have a slightly higher oxygen permeability, but they are transparent and 
much easier for processing than PEEK. The use of thermoplastic polymers together with fabrication 
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techniques such as injection moulding allows to produce microdevices for industrial scale[178] 
(paper I). Table 1 contains oxygen permeabilities of different polymers calculated in commonly used 
units (the data was gathered from different sources including different vendor´s datasheets). 
 
Table 1. Oxygen permeability of different polymers: PDMS - poly(dimethylsiloxane), FEP - fluorinated ethylene 
propylene, COC - cyclic olefin copolymer, PC – polycarbonate, PMMA - poly(methyl methacrylate), ETFE - poly(ethylene-
co-tetrafluoroethylene), PEEK - poly(ether ether ketone). 
Polymer 
Oxygen permeability 
Barrer cm3·mil·100inch-2 ·24h-1·atm-1 cm3·mm·m-2·24h-1·atm-1 m3·m·m-2·s-1·Pa-1 
PDMS 800.0 133 333 2 067 183 6.00·10-15 
VITON® 14.0 2 333 36 176 1.05·10-16 
FEP 4.5 748 11 600 3.37·10-17 
COC 2.6 428 6 641 1.93·10-17 
PC 1.8 302 4 677 1.36·10-17 
PMMA 1.4 225 3 488 1.01·10-17 
ETFE 0.6 100 1 550 4.50·10-18 
PEEK 0.1 20 309 8.97·10-19 
6.2 Control of dissolved oxygen concentration in microdevices 
The first step to control the dissolved oxygen concentration in perfusion based cell culture chips 
is the choice of right construction material. However, in order to be able to steer the concentration, 
active removal or supply of oxygen is required. 
The direct oxygen generation by electrolysis of water molecules has been proposed by Park  at 
al[183]. This technique requires microelectrode fabrication and potentially can lead to small 
concentrations of hydrogen peroxide, generated in the same process. A different approach is to 
exploit the very high diffusivity and solubility of oxygen in PDMS[161-163].  
Active removal of dissolved oxygen from a liquid at the macroscale can be achieved in many 
ways. These include bubbling liquid with nitrogen gas, electrochemical reduction of dissolved oxygen, 
biological consumption or chemical reaction with an oxygen scavenger[183-186]. At the microscale 
the first method would lead to extensive drying of the liquid, while the other two complicates the 
fabrication of the system. 
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There are a few recently published examples of the use of PDMS based microfluidic chips in 
which the authors are using nitrogen or nitrogen-oxygen gas mixtures to develop dissolved oxygen 
gradients[187-189]. The main advantage of such a solution is the possibility of reaching dissolved 
oxygen concentrations above the air saturation point (9.2 ppm at 293K and 1013.25 hPa)[163]. The 
main disadvantages are the complexity of the setup and the possibility of slowly drying out the 
chamber when a low liquid media flow is used.  
6.3 Oxygen scavengers 
The use of oxygen or other gas containers is difficult in cell culture labs, due to safety reasons 
and usually very confined space. Therefore, the application of a liquid oxygen scavenger is preferable 
over systems that rely on such gas containers in order to control the specific oxygen levels. Direct 
addition of an oxygen scavenging agent such as sulphite or pyrogallol to the cell culture media will 
alternate its chemical composition, which will have a heavy impact on the cultured organisms[190]. 
Therefore the technique which allows separating an oxygen scavenging liquid from the cell culture 
media is preferable. This can be achieved by using a gas permeable PDMS membrane. The control of 
the oxygen gradient across the cell culture microchamber can be realised by the combination of the 
diffusive and advective oxygen transport within the microchip (paper III, IV and V).  
6.4 Oxygen sensing 
It is crucial to be able to monitor the oxygen concentration at the microscale and here the 
classical amperometric method is not feasible because of the bulkiness of sensors and restriction to 
only point measurements. The most recent progress in miniaturization of the Clark electrode[191] 
allows one to build an electrode microarray[192, 193], which would allow monitoring gradients 
within microfluidic devices in the future. However, most widely used techniques for measurements 
of oxygen concentrations in microfluidic devices are based on optical methods, which involve 
photoluminescent dyes or polymer matrices doped with these probes[194, 195]. The basic 
phenomena responsible for oxygen sensing is dynamic quenching of the luminescence by molecular 
oxygen[196]. Most of the probes with very high quenching constants are based on either ruthenium 
complexes, such as tris(bipyridyl)ruthenium(II)[197] and Ru(II)-tris(4,7-diphenyl-1,10-
phenanthroline)[198-200] or metalloporphyrins, mainly platinum(II) and palladium(II) 
octaethylporphyrin (accordingly PtOEP and PdOEP)[201-205] (paper IV) and platinum(II) meso-tetra 
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(pentafluorophenyl) porphyrin (PtTFPP)[202, 206, 207] (paper V). Other probes, like Erythrosin 
B[208] or pyrene[209], are also reported as suitable for oxygen sensing purposes. 
The main advantage of the metalloporphyrin based sensors over complexes of ruthenium based 
sensors is the much higher sensitivity. This is especially important for sensing not pure oxygen, but 
atmospheric air saturated cell culture media, where the air saturation scale remains biologically 
relevant. Metalloporphyrins are non-soluble in water which is the main reason why 
mettaloporphyrins are usually embedded in polymers or silicone sol-gel matrices[202, 210]. 
Consequently, ruthenium complexes as water-soluble compounds can be added directly to the 
culture media[189], which definitely would simplify the task of sensing the dissolved oxygen 
concentration of the media. Such an addition would however lead to unspecified alterations in the 
metabolism of the cultured cells[163]. 
Therefore organically modified silica (ORMOSIL) are widely used as a sensor matrix[202]. The use 
of ORMOSIL is advantageous over direct dissolution of the sensing molecule in the culture media due 
to its chemical inertness[211] and the possibility of relatively easy surface modifications[59]. 
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7 Fabrication techniques of polymer microfluidic devices 
Initially, microfluidic devices were mainly fabricated in silicon. This was due to the well-known 
technology of microstructures fabrication developed for the electronic industry[212]. The use of the 
technologies for microfabrication in silicon brings, however, some major drawback. First of all, the 
costs of microfabrication in silicon are very high, especially for prototyping and small batch 
production. This is due to the requirements for using cleanroom facilities, long fabrication processes 
and expensive materials. Besides, the physical and chemical properties of silicon are not optimal for 
some applications, especially for microdevices used for cell culturing. Among these properties the 
minor issues are biocompatibility, lack of optical transparency in the UV and the visible range and 
chemical incompatibility with e.g. alkaline environment[213-215].  
On the other hand, there is a wide range of choice of polymers. Such polymers as polystyrene, 
polycarbonate, poly(methyl methacrylate), poly(dimethylsiloxane), cyclic olefin copolymer and many 
others are relatively cheap, optically transparent and are for most biological application relatively 
biocompatible. The development of different microfabrication techniques for quick prototyping 
(micromilling, laser ablation, mould casting) as well as for mass production (injection moulding, hot 
embossing) allow to use polymer based microdevices in a wide range of applications[216-218]. 
7.1 Micromilling 
Milling is a well known abrasive method for fabrication in polymers as well as in metal, alloys, 
wood and many others. Downscaling of the tools and components brings additional challenges to 
micromilling machines, micromilling and microdrilling tools. These tools have their diameters usually 
much below 1 mm. Up to date, the smallest end mills offered on the market have a diameter of 
5 µm[219]. One of the important issues are small vibrations and excessive forces applied to the 
micromilling tools[220]. For the smallest tools it can be challenging to assess their integrity with a 
naked eye[221, 222]. 
Although the micromilling technique can be used for fabrication in a wide range of polymers, for 
some materials it can be challenging to obtain the desired structures without flaws. One of the most 
important issues is burrs formation[223]. Therefore, milling parameters such as feed rate, spin rate 
and use of coolant need to be carefully selected as well as  the tool path and milling strategies need 
to be optimised for each material[224, 225]. Another disadvantage of micromilling is the relatively 
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high roughness of the machined surface. In order to decrease the surface roughness, mechanical or 
chemical polishing can be performed[226]. This is especially important for optical application of 
microdevices fabricated by milling. 
The micromilling technique can be used for direct structures fabrication (paper I-VI). Due to the 
undoubted advantage in its flexibility, this technique is particularly useful for quick prototyping. 
However, for mass production purposes other techniques as injection moulding and hot embossing 
are usually a better choice. In this case micromilling can be used for fabrication of moulds and 
stamps[227-229]. 
7.2 Laser ablation 
The other useful technique for fabrication of microstructures is laser ablation. This is a process in 
which the material is removed from a solid surface by a laser beam[230]. Two types of lasers: 
excimer laser and CO2 laser are commonly used. In general, the excimer laser wavelengths are in the 
UV range (e.g. 196 nm for ArF laser and 248 nm for KrF laser) while the CO2 laser operates with near 
infrared radiation (10.6 µm). The advantages of the CO2 laser over the excimer laser are its cost-
effectiveness[231, 232] and high speed of ablation while the main disadvantage is a relatively large 
beam diameter[233]. The Gaussian shape of the beam brings further constrains to the flexibility of 
this technique[234]. 
The CO2 laser ablation has been shown particularly useful for quick prototyping of 
microstructures in PMMA[231-234]. Furthermore, it is possible to use this technique for fast and 
precise cutting of foils and membranes[235-239] (papers III-VII). 
7.3 Mould casting 
PDMS is one of the most commonly used materials for quick fabrication of microdevices, 
particularly for applications in life science. The most useful technique for forming the microstructures 
in this material is by casting the uncured mixture of the polymer, catalyst and curing agent against 
the mould[166](papers III-VI). In order to crosslink the polymer chains and to form a rubber, a 
thermal curing follows the casting. The mould is usually fabricated using either micromilling or 
photolithography techniques[142]. 
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7.4 Bonding of microfluidic chip 
Today’s wide range of fabrication methods for microfluidic devices allows to reproduce almost 
any kind of shapes and dimensions in different materials. However, it still might be challenging, in 
some cases, to perform robust and reliable bonding between different chip layers. This is particularly 
problematic if one wants to integrate different materials in one functional microfluidic chip. 
The microfluidic devices fabricated from thermoplastic materials such as PMMA, PC, COC, PS are 
relatively easy to bond using either thermal fusion bonding[240-242] or solvent assisted 
bonding[182, 243, 244]. 
The general rule for thermal fusion bonding of thermoplastics is to heat up the material near or 
above its glass transition temperature (Tg) and apply a pressure in order to increase the surface of 
contact[245]. It is possible to use this technique to bond different thermoplastics as long as the 
materials have similar Tg. Sometimes, the surfaces of the substrates need to be treated (e.g. with 
UV[246] or plasma[247]) before bonding. These treatments are used to locally lower the Tg of the 
materials and to enhance the bonding strength. Careful optimisation of the bonding parameters 
(temperature and pressure) as well as the possible pre-treatment is always needed. 
The other way to bond the thermoplastics is to use solvent assisted bonding. This method can be 
employed even to bond materials with different Tg as long as the different materials have no 
tendency to separate from each other and are soluble in the used solvent[245]. Moreover, the 
exposition of the machined surface to the solvents vapours can reduce its roughness and be used as 
a polishing step[226]. This was one of the methods applied for bonding the devices described in 
papers V-VII. 
In order to bond materials belonging to different groups like thermoplastics and elastomers (e.g. 
PC and PDMS) an intermediate adhesive layer is needed. The choice of the adhesive depends on the 
type of materials to be bonded. One of the easiest ways is to use a pressure activated adhesive 
transfer tapes[248]. These commercially available tapes can be die cut or laser cut to the desired size 
and shape.  This method has been exploited to bond PDMS to thermoplastic substrates in papers 
III-V. 
 39 
8 Publications 
 41 
8.1 Paper I 
Skolimowski, M., Tofteberg, T., Andreassen, E., and Geschke, O., A novel passive 
micromixer suitable for mass production in polymers. The 25th Annual meeting of The 
Polymer Processing Society, conference proceedings, 2009. 
 
A novel passive micromixer suitable for mass production in polymers  
 
Maciej Skolimowski1*, Terje Tofteberg2, Erik Andreassen2 and Oliver Geschke1 
1 Technical University of Denmark, Department of Micro- and Nanotechnology, Produktionstorvet, 
Building 423/118, DK-2800 Kgs. Lyngby, Denmark 
2 SINTEF Materials and Chemistry, PO-Box 124 Blindern, 0314 Oslo, Norway 
 
*maciej.Skolimowski@nanotech.dtu.dk, tel: +45 25 6887, fax: +45 4588 7762 
 
Abstract: This paper presents a novel passive micromixer concept that creates direct lamination in a 
2D channel. The principle is to make a controlled 90 degree rotation of the flow cross section followed 
by a splitting into several channels; the flow in each of these channels is rotated further 90 degrees 
before recombination. The 90 degree rotation is achieved by patterning the channel bed with ribs. The 
effect of the mixers has been studied using simulations and prototypes have been made using direct 
micromachining of polymer. Confocal microscopy has been used to study the mixing. The main 
advantage with the presented design is that the channels can be made in one part which only has to be 
sealed by a planar lid e.g. by laser welding or thermal bonding. The geometry and simplicity of this 
design made it suitable for mass production in various polymers using injection moulding techniques. 
 
Keywords: micromixer, injection molding, polymers, computational fluid dynamics, microfabrication 
 
Introduction: A mixing process, very well know at the macro level, is still a challenge to realise at 
microscale. This is especially important in mass production of polymeric devices with integrated 
micromixer units. The micromixers are usually divided into passive and active devices according to the 
source of energy that is used for mixing (Nguyen and Wu, 2005). 
Active mixers, where the external source of energy is needed, are relatively complex and expensive to 
build. Still, due to very low Reynolds number in the microscale, active mixing by introducing 
turbulence is by far not as effective as at the macroscale. 
What is a main cause of problems in the case of active micromixers is, in contrary, a strong advantage 
in case of passive micromixers. Small dimensions of the channels enable us to use diffusion as a 
driving force. Still, to achieve an effective mixing, lamination of the fluid is often employed.  
The most straightforward solution is to divide two fluids that are going to be mixed into small streams 
and then join them alternately. Hinsmann et al. (2001) proposed a 3D structure device based on this 
idea. The device was fabricated in SU-8 epoxy-polymer with a procedure involving several 
photolithography and metal deposition steps. Slightly different devices were proposed by Cha et al. 
(2006). The authors used poly(dimethylsiloxane) (PDMS) as a main construction material. Fabrication 
by this process involves fabrication of silicon moulds and precise aligning of several PDMS layers. 
Other solutions are based on the work of Stroock et al. (2002) where microstructures enable a fluid 
rotation in channels. Since then several micromixers based on these structures, called staggered 
herringbones have been proposed. The mixing usually takes place in the relatively long microstructured 
channels. 
In this work the authors propose a novel approach to micromixing based on rotation, splitting and 
joining fluids in microchannels. The main goal was to develop an effective micromixer that can be 
easily and not expensively mass produced in polymer e.g. by injection moulding techniques. 
Design and fabrication: Figure 1 shows the micromixer design with dimensions. The prototype of the 
device was fabricated by micromilling (Mini-Mill/3PRO, Minitech Machinery Corp., USA) in 
poly(methyl methacrylate) (PMMA, Röhm GmbH & Co. KG, Germany) and sealed with a lid using 
adhesive thin film (ARcare® 91005, Adhesive Research Ireland Ltd.). Alternatively thermal bonding 
and laser bonding were used. This particular fabrication strategy was chosen due to similarity with 
mould fabrication for injection moulding techniques. Other successfully tested fabrication processes 
involve direct laser ablation (48-5S Duo Lase carbon dioxide laser, SYNRAD Inc., USA) in PMMA. 
Results: The lamination in one mixing module was investigated using 3D finite volume simulations in 
ANSYS CFX 11.0. We used a procedure similar to the one recommended by Mendels et al. (2008). 
The two fluids are treated as isothermal and incompressible Newtonian fluids following the Navier-
Stokes equations. Fabricated prototype efficiency was analysed using scanning laser confocal 
microscopy (Zeiss LSM 510 Meta, Brock og Michelsen A/S, Denmark). Two fluorescent dyes: 
Fluorescein and Rhodamine B (Sigma-Aldrich Denmark A/S) were used. Figure 2 shows the high 
degree of conformity between the simulated and measured rotation of the fluids in the microdevice. 
Almost complete mixing was achieved after 3 modules as shown on Figure 3. 
Discussion and conclusions: The presented device was proven to be an effective micromixer, yet 
relatively simple in fabrication. Moreover, the mixer can easily and efficiently be stacked on a limited 
surface as shown on Figure 4. The device can be fabricated in one single piece of substrate and does 
not need any alignment steps which is a substantial advantage over 3D devices known from the 
literature. Furthermore it can be produced from relatively inexpensive polymers like PMMA or 
polystyrene. 
Results from the tests of the different fabrication strategies show that the microdevice can be produced 
in mass scale with techniques like injection moulding and laser ablation. This is especially important in 
applications such as medical diagnostics where cost effective, disposable micromodules are preferably 
used. 
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Fig.1: Above: Design showing four mixing 
modules. Below: Detailed view of the grooves 
with dimensions indicated [mm]. 
 
 
 
Fig 2: Simulated and measured concentration 
distributions within one mixing module 
 
Fig 3: Left: Confocal microscopy images 
showing planes at z = h/2, where h is the channel 
depth. The images show the intensity after 0, 1, 2 
and 3 full modules. Right: Normalized intensity 
of the two flourophores measured across the cross 
sections on the left. 
 
 
Fig 4: Simulated flow field in one compact 
mixing module showing lamination 
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Abstract A novel passive micromixer concept is pre-
sented. The working principle is to make a controlled 90
rotation of a flow cross-section followed by a split into
several channels; the flow in each of these channels is
rotated a further 90 before a recombination doubles the
interfacial area between the two fluids. This process is
repeated until achieving the desired degree of mixing. The
rotation of the flow field is obtained by patterning the
channel bed with grooves. The effect of the mixers has
been studied using computational fluid mechanics and
prototypes have been micromilled in poly(methyl meth-
acrylate). Confocal microscopy has been used to study the
mixing. Several micromixers working on the principle of
lamination have been reported in recent years. However,
they require three-dimensional channel designs which can
be complicated to manufacture. The main advantage with
the present design is that it is relatively easy to produce
using standard microfabrication techniques while at the
same time obtaining good lamination between two fluids.
Keywords Passive mixer  Micromixer 
Split-and-recombine mixer  Confocal microscopy 
Micromilling  Simulations
1 Introduction
At high Reynolds numbers (typically [2400) two fluids
can readily be mixed by turbulence. In microchannels with
cross-sections less than one millimeter, this becomes dif-
ficult to achieve. For water at room temperature, turbu-
lence in such a channel would require a velocity of several
meters per second, which, in most cases, is unfeasible.
Mixing of two fluids can still be easily done if the Peclet
number is small enough. The Peclet number is defined as
the ratio between advection time and diffusion time as
Pe = uL/D, where u is the characteristic velocity, L the
characteristic length and D the characteristic diffusion
coefficient. When Pe is small, diffusion is fast compared
to advection, meaning that mixing can usually be left to
diffusion alone, e.g. as in a T-type mixer (Wong et al.
2004). This will be the case if the channels are either very
small or the diffusion coefficient is very large. In the
domain where the Reynolds number is small and the
Peclet number is large, mixing becomes difficult. In
microchannels this typically occurs if the channel dimen-
sions are between 1 and 1,000 lm for species with low
diffusivity.
There are several principles already available to achieve
mixing in microchannels. Nguyen and Wu (2005) pre-
sented an overview of some of the mixers available. The
coarsest classification of mixers in their article is between
active and passive mixers. Active mixers can, for example,
utilize pressure field disturbances (Rife et al. 2000; Niu and
Lee 2003) or ultrasonic devices (Yang et al. 2001) to mix
fluids. If the fluids are electrolytes, time-dependent electric
or magnetic fields (Bau et al. 2001; Glasgow et al. 2004)
can be used. It is also demonstrated that moving magnetic
beads in a changing magnetic field can efficiently mix
fluids (Suzuki and Ho 2002).
T. Tofteberg (&)  E. Andreassen
SINTEF Materials and Chemistry,
PO Box 124, Blindern, 0314 Oslo, Norway
e-mail: terje.tofteberg@sintef.no
M. Skolimowski  O. Geschke
Institute for Micro- and Nanotechnology,
Technical University of Denmark,
Building 423, 2800 Kgs Lyngby, Denmark
123
Microfluid Nanofluid (2010) 8:209–215
DOI 10.1007/s10404-009-0456-z
In contrast to active mixers, passive mixers are sta-
tionary and do not require any external energy input apart
from the pressure drop required to drive the flow. In gen-
eral, this makes passive mixers simpler to fabricate and
fewer external connections are needed. In the review by
Nguyen and Wu, the passive mixers for microchannels are
subdivided into five categories:
(1) Chaotic advection micromixers: the channel shape is
used to split, stretch, fold and break the flow. One
way of achieving this is to introduce obstructions to
the fluid flow in the channel (Bhagat et al. 2007; Lin
et al. 2007; Hsieh and Huang 2008). Another is to
introduce patterns on the channel walls that rotate the
flow field, as in the staggered herringbone mixer
(Stroock et al. 2002).
(2) Droplet micromixers: droplets of the fluids are
generated and as droplets move an internal flow field
is generated within the droplet causing a mixing of
fluids. The first such mixer was demonstrated by
Hosokawa et al. (1999).
(3) Injection micromixers: a solute flow is splitted into
several streams and injected into a solvent flow
(Voldman et al. 2000).
(4) Parallel lamination micromixers: the inlet streams of
both fluids are splitted into a total of n substreams
before combination. For n = 2, this is the classic T-
type mixer. By increasing n, the diffusion length can
be decreased (Bessoth et al. 1999).
(5) Serial lamination micromixers: the fluids are repeat-
edly splitted and recombined in horizontal and
vertical planes to exponentially increase their inter-
facial area. One well-known example is the Caterpil-
lar mixer (Scho¨nfeld et al. 2004) but other similar
designs have also been proposed (Cha et al. 2006; Xia
et al. 2006).
In this report we present a lamination mixer that is
similar to the serial lamination mixers. However, whereas
both the parallel and the serial lamination mixers described
in the literature need out of plane channels to split and
rejoin the streams, our mixer has all channels in one plane.
This means that the mixer can be fabricated by just bonding
a planar lid on the top of a structured channel. On the other
hand, a three-dimensional channel will need at least two
structured parts which have to be aligned precisely in the
fabrication process. Thus, the main advantage of the
present mixer when compared with active mixers and other
lamination mixers is the ease of fabrication. The structures
can easily be mass produced using polymer replication
techniques such as injection molding or hot embossing.
To the authors knowledge this is the first time a mixer
working on the principle of splitting and recombining in
such a simple design is presented. In order to achieve the
folding, the flows are rotated 90 between each splitting
and rejoining. This helical flow pattern is achieved by
patterning the channel bed. An illustration of a mixing
module of this kind is shown in Fig. 1. In this figure, the
simulated streamlines are colored according to their origin.
The present mixer has been realized using several
microfabrication techniques.
• Direct laser ablation of channels and grooves in
poly(methyl methacrylate) (PMMA).
• Direct micromilling in polycarbonate (PC) and PMMA.
• Milling of the negative structure in aluminum and
replication with injection molding in polystyrene (PS).
• Milling of the negative structure in PMMA and
replication in polydimethylsiloxane (PDMS).
The results presented in this article relate to mixers
milled directly in PMMA. We want to emphasize that the
design, because of its open structure and lack of intricate
details, can easily be realized using a range of microfab-
rication techniques.
2 Procedure
2.1 Microfabrication
As a main fabrication method micromilling (Mini-Mill/
3PRO, Minitech Machinery Corp., USA) in PMMA (Ro¨hm
GmbH & Co. KG, Germany) was used. First, channels with
depth of 50 lm and width of 300 lm (equal to the diameter
of the tool) were milled. In the bed of the channels 200 lm
wide grooves were fabricated using a [100 lm milling
tool. This tool diameter was chosen to minimize the fillet
radius on the corners of the grooves. Cut feed speed was
70 mm/min and spindle rotation was 4,000 RPM.
As an alternative fabrication method, laser ablation
(48-5S Duo Lase carbon dioxide laser, SYNRAD Inc.,
USA) was used. The channels were obtained using a 10 W
laser beam (wavelength 10.6 lm) and a focusing lens with
Fig. 1 Simulated flow field in one mixing module showing lamina-
tion in the Stokes flow regime (Re \ 5). The two fluids enter in the
upper left corner. The interfacial area between the two has approx-
imately tripled at the exit in the lower left corner
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200 mm focal length (beam diameter 290 lm). The abla-
tion velocity was adjusted to 300 mm/min. For ablation of
200 lm grooves, an 80 mm focal length lens was used
(beam diameter 90 lm) and the power was reduced to 4 W.
Ablated structures had a Gaussian-like cross-section as
reported earlier (Klank et al. 2002).
The microdevice was sealed with a lid using a silicone
adhesive thin film (ARcare 91005, Adhesive Research
Ireland Ltd.). Thermal bonding and laser bonding methods
also gave good results.
2.2 Confocal laser scanning microscopy measurements
To investigate the performance of the designed micromixer
two dyes were used: Rhodamine B and Fluorescein. The
dyes were dissolved in phosphate buffered saline (pH 7.4)
with 0.2% sodium dodecyl sulfate (SDS) (all from Sigma-
Aldrich, Denmark A/S). Confocal laser scanning micros-
copy (Zeiss LSM 510 Meta, Brock og Michelsen A/S,
Denmark) was done using a 409 Fluar oil immersion
objective. A 488 nm Argon laser was used for exciting
Fluorescein and a 543 nm HeNe laser for Rhodamine B.
The pinhole was adjusted for approximately 5 lm z axis
slice thicknesses. The solutions were pumped through the
microdevice by a syringe pump (model 540060, TSE
Systems GmbH, Germany) with flow-rate according to the
desired Reynolds number.
2.3 Simulations
The mixing efficiency was investigated using 3D finite
volume simulations in ANSYS CFX 11.0. The procedure
adopted is similar to the one described by Mendels et al.
(2008) where the fluids are treated as isothermal and
incompressible Newtonian fluids following the Navier–
Stokes equations.
r  u ¼ 0 ð1Þ
q
ou
ot
þ u  ru
 
¼ rp þ gr2u ð2Þ
Here u is the velocity vector, q the density, g the viscosity
and t the time. To track the location of the interface
between the two fluids an additional concentration variable
c is transported through the domain by convection and
diffusion.
oc
ot
þ u  rc ¼ Dr2c ð3Þ
Since the mixer works by lamination, the efficiency of the
mixer was best evaluated in the absence of diffusion,
therefore the diffusion coefficient, D, was set to 0 in the
simulations.
At the inlet, a sharp step in c is prescribed, representing
two completely separated fluids. Because of numerical
diffusion, it is necessary to have a fine mesh at the interface
between the two phases. This interface is not initially
known and in order to define a fine mesh here, an adaptive
meshing procedure was used. Equations 1–3 were first
solved on a relatively coarse mesh. When convergence was
obtained, the mesh was refined where the variation in c
over an element edge exceeded a given value. This pro-
cedure was repeated six times with an increasingly finer
mesh, until convergence in mesh size. The fluid properties
in the simulations are the same as water at 20C with
g = 1.002 mPa s and q = 998 kg/m3.
2.4 Validation
To validate the simulations, a channel was made using
laser ablation. The channel has a cross-section of
300 lm 9 50 lm, and 50 lm deep, 200 lm wide grooves
inclined 55 relative to the channel axis. The shape of the
grooves was measured using confocal microscopy and the
measured geometry was used as a basis for simulations.
The resulting rotation can be seen in Fig. 2. It can be seen
that there is a good qualitative agreement between the
simulated and measured rotations. Using this geometry, the
closest thing to a 90 rotation occurs after three grooves. It
can also be seen that after six grooves, a full 180 rotation
is observed in the simulations. The experimental data
indicates that this rotation is taking place already after five
grooves. Note also the almost perfect match between the
cross-section after the first and seventh grooves in the
simulations, which is also seen after the first and sixth
grooves in the experiments.
2.5 Design optimization
As can be seen in Fig. 2, the rotation after three grooves is
not exactly a straight angle. There is also some deformation
of the interface between the two tracers; it is no longer a
straight line as was the case at the inlet. Three design
parameters were varied in a full factorial design to see how
a 90 rotation could best be achieved:
• the groove angle (45–55–65),
• the depth of the grooves (50–100–200 lm),
• the depth of the channel (50–100–200 lm).
The channel width was fixed to 300 lm. The design
optimization was performed using simulations in CFX of
straight channels to find the configuration that gave a
rotation of the flow as close to 90 as possible. The best
results were obtained with a groove angle of 55, a channel
depth of 50 lm and a groove depth of 50 lm which are the
parameters used in the following experiments. This optimal
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design is shown with dimensions in Fig. 3. Note that this is
not a global optimum but only the optimum within the
limited space sampled. Other authors have studied the
optimization of helical flow patterns by patterning the
channel (Yang et al. 2005, 2008) and it is likely that further
optimization of the structure is possible.
3 Results and discussion
The lamination observed experimentally and in simula-
tions, for one module, is shown in Fig. 4. There is a good
agreement between the simulated and measured rotations
of the flow field. It is also demonstrated that the mixer is
able to laminate the flow field as desired.
The lamination, as measured with confocal microscopy,
after one to four modules is shown in Fig. 5a. Note that
after three modules the two fluids are mixed well. The
different laminae can still be seen, demonstrating that it is
the stretching and folding effect of the device that is
mixing the fluids. The mixing efficiency will in general be
dependent on the Peclet number, showing better mixing at
lower Peclet numbers. The diffusion coefficients for Rho-
damine B and Fluorescein alone in water are 3.6 9 10-10
and 4.9 9 10-10 m2/s, respectively (Rani et al. 2005). Note
that Rhodamine B is hydrophobic and is likely to form
micelles with sodium dodecyl sulfate, increasing the dif-
fusion coefficient. This increased diffusion coefficient was
not measured. The Peclet number for Fluorescein in the
setup shown in Fig. 5 is 9700. The effective Peclet number
for Rhodamine B is probably larger than for Fluorescein
because of the micelles. This is indicated by the fact that
the evaluated degree of mixing for Rhodamine B rises
slower than for Fluorescein as can be seen in Fig. 5c.
In the original staggered herringbone article by Stroock
et al. (2002), the efficiency is evaluated by measuring the
standard deviation r in fluorescence at different locations.
The distance required to achieve a reduction in standard
Fig. 2 Helical rotation of the flow field in a straight channel with
grooves on the channel bed in the Stokes flow regime (Re * 1). Left
confocal fluorescence microscopy measurements of the distribution of
rhodamine (red, left at the inlet) and Fluorescein (green, right at the
inlet). Center simulated flow field. Right photography showing a top
view of channel. The numbers indicate the cross-section after a given
number of grooves, which can be seen in the right image
Fig. 3 Design showing four mixing modules (above). Detailed view
of the grooves with dimensions indicated (in mm) (below). The main
channel is 50 lm 9 300 lm with 50 lm deep, 200 lm wide grooves,
inclined 55 relative to the channel axis
Fig. 4 Concentration distributions within one mixing module. The
images on the geometry show the simulated distribution and the outer
ones are confocal microscopy measurements
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deviation by 90% relative to the inlet, Dy90, is taken as an
indication of the length of mixer required. This standard
deviation for the present mixer is seen in Fig. 3d after one
to four full modules and it can be seen that this criterion
has been met for the fluorophore with the highest diffu-
sivity, Fluorescein, after four modules. The larger, and
slower diffusing rhodamine B is close to achieving this
criterion. In Stroock et al. this criterion is met after
between 3.5 (Pe = 2000) and 8.5 (Pe = 2 9 105) rotation
cycles. Note that the standard deviation measure for mixing
will be dependent on the resolution of the confocal
microscopy used and therefore these values for mixing
efficiency are not directly comparable from study to study.
They are still included here for an indication of the mixing
efficiency.
To quantitatively evaluate the mixing efficiency, we
define the index of mixing as in (Liu et al. 2004) as
Cmix ¼ rinlet  rrinlet ð4Þ
where r is the standard deviation of the fluorescence
intensity. They use simulation to evaluate the mixers and
sigma is the standard deviation in the concentration of a
phase variable. They find that the index of mixing for the
herringbone mixer when mixing solutions of glycerol and
water is approximately 0.5 (Pe = 1000) after two full
mixing cycles. The mixing index for the present mixer is
shown in Fig. 5c.
3.1 Reynolds number dependence
The simulated lamination for two different Reynolds
numbers is shown in Fig. 6. Up to a Reynolds number of 5
(flow rate 50 ll/min), changing the flow rate does not
change the lamination process. The characteristic length, is
in this case, taken as the hydraulic diameter of the channel
(85 lm) and the characteristic velocity is the volume flow
divided by the channel cross-section (300 lm 9 50 lm)
where no grooves are present. It can be seen that in the
Stokes flow regime, almost perfect lamination is observed.
As the momentum effects become more important,
Fig. 5 a Confocal microscopy
images showing planes at
z = h/2, where h is the channel
depth. The images show from
the top the intensity at the
entrance and after one to four
full modules (Re = 5). The
modules can be seen in Fig. 3.
b Normalized intensity of the
two fluorophores measured
across the cross-sections in a.
c The index of mixing evaluated
using the variance in the data
from b. d The standard
deviation of the intensities from
b including a line showing the
criteria used for mixing
Fig. 6 Simulated lamination as a function of the Reynolds number.
For Re \ 5, the profiles are independent of Re to the accuracy of this
graphical representation
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however, the helical rotation of the flow field changes. The
structure still works as a mixer, but since the helical rota-
tion outside the Stokes flow regime is Reynolds number
dependent, it is not given that the two substreams join each
other after the designed 90 rotation for Reynolds number
above five. For the staggered herringbone mixers, which
also reliy on grooves on the channel bed to rotate the flow
field, it has been reported that at high Reynolds numbers
([10) vortices form in the grooves which significantly
reduce the rotation (Williams et al. 2008). Similar effects
are also seen for three-dimensional mixers working on the
split and recombine principle, for example, good lamina-
tion is only observed with the caterpillar mixers for low
Reynolds numbers (\30, Scho¨nfeld et al. 2004).
3.2 Stacking of design
In this report, the focus has not been on making the design
as compact as possible. This can, however, be done when
considering the layout in Fig. 1. By changing the direction
of flow after each rotation of the flow field the overall
shape of one mixer module is rectangular. The module
shown measures 1.5 9 1.7 mm and the rectangular overall
shape makes it easy to pack it densely on a chip device.
4 Conclusions
A new concept for a passive micromixer has been
developed. It is shown that the combination of patterning
the channel bed and splitting and recombining the streams
can be used to make controlled lamination in a 2D
channel system. This is shown using both numerical
simulations and experiments with prototypes. The design
can easily be realized using a range of microfabrication
techniques and mass produced using, for example, injec-
tion molding.
In the design optimization used in this work only a small
subset of the design parameter space was investigated. A
further optimization of the design with respect to mixing
efficiency on an area as small as possible should be carried
out in the future. It is also possible to change the mixer to
divide the flow into more than two substreams. Preliminary
studies indicate that splitting into three or four substreams
can be used to obtain better mixing on a smaller area.
Further examination of this question should be made in the
future.
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ABSTRACT
Here we report work towards development of a microfluidic system that can 
simulate the aerobic and anaerobic conditions in the human airways. The main pur-
pose of this device is to mimic habitats of bacteria that usually attack airways of cys-
tic fibrosis (CF) patients. The presented system enables the study of formation, 
growth, and dissolution of the bacterial biofilms, which is the main cause of the 
massive pulmonary deficiency and eventually death of CF patients. The ultimate 
goal for the microdevice is to replace the existing animal models (mice) in the de-
velopment of new drugs and new treatment strategies in CF. 
KEYWORDS: biochip, cystic fibrosis, biofilm, airways, microsystem 
INTRODUCTION
The airways consist of at least three independent compartments, the conductive 
airways (the trachea, bronchii and bronchioles), the oxygen exchange compartment 
(alveoles) and a third, less recognized compartment, the paranasal sinuses (maxillary 
sinuses, frontal sinuses and ethmoid sinuses). In the first and the last compartment 
the environment is essentially anaerobic while in the alveoles the environment is 
highly aerated. 
THEORY
To simulate the environ-
mental conditions, especially 
the oxygen level which is 
major parameters affecting 
biofilm growth in CF pa-
tients, we propose the micro-
fluidic airways model (Fig-
ure 1). The model consists 
of microchambers for bacte-
rial biofilm growth and mi-
crofluidic channels for pro-
viding oxygen-scavenging 
liquid or oxygen-rich liquid. 
To avoid any impact on the 
Figure 1.  Human airways system, (B) top view 
sketch of Microfluidic Airways Model (MAM) and 
(C) cross-section view of MAM 
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growth of microorganisms from these liquids, the compartments are separated by an 
oxygen permeable membrane. All media and liquid flow is controlled by external 
pumps. The oxygen level in the chambers can be controlled by varying the flow 
rates (Figure 3). A sensing layer for oxygen concentration measurements was incor-
porated at the bottom of the chambers. To provide the possibility of tracking bacte-
rial re-infections, the bacteria growth chambers exposed to different oxygen levels 
were interconnected with channels (Figure 1 B).  
EXPERIMENTAL 
The biochip (Figure 2) was fabricated by micromilling of inlets and outlets and 
laser ablation of the channels in poly(methyl methacrylate). Poly(dimethylsiloxane) 
(PDMS) was used as the oxygen permeable membrane. The oxygen permeability of 
PDMS is a well known property, and its use for supplying oxygen in microdevices 
has been reported [1,2]. However, to our knowledge, no applications comprising ac-
tive removal of oxygen by means of utilizing concentration gradients below oxygen 
saturation has been reported. This mechanism mimics the physiological oxygen ex-
change in the airways compartments. The lid comprising the oxygen sensing layer 
was fabricated by doping uncured PDMS with platinum(II) octaethylporphyrin 
(PtOEP), diluted with THF and spincoated to a thickness of approx. 15 μm on a 100 
μm thick glass lid followed by thermal curing. Substitution of the usually used sen-
sor matrix (ORMOSIL) [3] with PDMS allows to perform biological experiments in 
a 100 μm deep microchamber that is constructed from uniform material. All layers 
were sealed by silicone adhesive tape. 
Figure 2: Designed (A) and fabricated (B) microdevice
To form the dissolved oxygen gradient in one of the culture chambers, oxygen 
scavenger (5% sodium sulphite water solution) was pumped through the correspond-
ing microchannel situated beneath the membrane. The second channel was con-
stantly flushed with oxygen saturated water.  
RESULTS AND DISCUSSION 
Formation of the oxygen concentration gradient inside the culture chamber was 
modelled, using  numerical simulation with COMSOL 3.4 software (Figure 3), and 
experimentally confirmed by photoluminescence lifetime recordings on a multilabel 
reader Victor2 (Perkin-Elmer Life Sciences) with the PtOEP sensing layer. 
A Glass with sensor for 
oxygen level imaging 
Culture chambers with 
media flow 
Channels with oxygen 
scavenging liquid 
Gas permeable membrane
Connection between 
chambers  
B
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The microsystem was used for bacterial biofilm culture. A Pseudomonas aerugi-
nosa strain, isolated from a CF patient (B54-1 WT-blue), was tagged with four dif-
ferent fluorescent proteins and inoculated. The experiment was carried out for 7 
days. The biofilm was formed in 2 days and was not dissolving during the entire ex-
periment. Confocal scanning laser microscopy was used for monitoring the biofilm 
formation (Figure 4).
0.1 ml·h-1 0.5 ml·h-1
2.0 ml·h-1
Figure 3: Left and 
above: oxygen gra-
dient in the designed 
microdevice at vari-
ous flow of the fluid in the chamber. Right: com-
parison between simulated and measured oxygen 
concentration
Figure 4: Confocal images 
of the bacterial biofilm for-
mation in the microdevice. 
Cells express different fluo-
rescent proteins (FP) (top: 
YFP, bottom from left to 
right: RFP, GFP, CFP).
CONCLUSIONS
The presented microfluidic chip was successfully used for generation of the oxy-
gen gradient, which was easily regulated by altering the media flow rate and moni-
tored by time-resolved photoluminescence measurements with integrated microsen-
sor. Separation of the oxygen scavenger allows utilising the chip for cell culture. 
The system was used for culturing of Pseudomonas aeruginosa biofilm. Future 
research will be focused on studies of the different antibiotic treatment strategies of 
bacterial biofilms. 
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A microfluidic chip for generation of gradients of dissolved oxygen was designed, fabricated and tested.
The novel way of active oxygen depletion through a gas permeable membrane was applied. Numerical
simulations for generation of O2 gradients were correlated with measured oxygen concentrations. The
developed microsystem was used to study growth patterns of the bacterium Pseudomonas aeruginosa in
medium with different oxygen concentrations. The results showed that attachment of Pseudomonas
aeruginosa to the substrate changed with oxygen concentration. This demonstrates that the device can
be used for studies requiring controlled oxygen levels and for future studies of microaerobic and
anaerobic conditions.
Introduction
The generation of concentration gradients of different chemicals
in microfluidic biochips is a problem often addressed in the
literature. Typically, for the water soluble components, these are
generated by diffusive mixing in microchannels by splitting and
merging streams with different concentrations of the molecules
of interest.1–6
In this work we address the creation of controlled oxygen
gradients in perfusion based cell culture chips. A few reports exist
that involve e.g., the direct oxygen generation by electrolysis of
water molecules,7 a technique that requires microelectrode
fabrication and that potentially can lead to small concentrations
of hydrogen peroxide, generated in the same process. A different
approach is to exploit the very high diffusivity and solubility
of oxygen in poly(dimethylsiloxane) (PDMS).8–10 PDMS is
a chemically inert, biocompatible and optically transparent
polymer11 that is very commonly used for fast construction of
microdevices.12,13 Its properties make it a popular material for
construction of cell culture based microdevices. Furthermore it
can be utilised as a component in an active scheme of oxygen
removal due to its gas permeability.
Active removal of dissolved oxygen from a liquid at the
macroscale can be achieved in many ways. These include
bubbling liquid with nitrogen gas, electrochemical reduction of
dissolved oxygen, biological consumption or chemical reaction
with an oxygen scavenger.7,14–16 At the microscale the first
method would lead to extensive drying of the liquid, while the
other two complicate the fabrication of such a system.
There are a few very recently published examples of the use of
PDMS based microfluidic chips in which the authors are using
nitrogen or nitrogen–oxygen gas mixtures to develop dissolved
oxygen gradients.17–19 The main advantage of such a solution
would be the possibility of reaching dissolved oxygen concent-
rations above air saturation point (9.2 ppm at 293 K and
1013.25 hPa).10 The main disadvantages are the complexity of the
setup and the possibility of slowly drying out the chamber when
a low liquid media flow is used.
The use of oxygen or other gas containers is difficult in cell
culture labs, due to safety reasons and usually very confined
space. Therefore, the application of a liquid oxygen scavenger is
highly preferable over systems that rely on such gas containers
in order to control the specific levels of oxygen gradients. Direct
addition of an oxygen scavenging agent such as sulfite or
pyrogallol to the cell culture media will alternate its chemical
composition which will have a heavy impact on the cultured
organisms.20 Therefore, in this paper we propose the use of a gas
permeable PDMS membrane to separate an oxygen scavenging
liquid from the cell culture media. To control the oxygen
gradient across the cell culture microchamber we rely on the
combination of the diffusive and advective oxygen transport
within the microchip. To the authors best knowledge, there is so
far no scientific report on such a system applied in biological
studies.
It is crucial to be able to monitor the oxygen concentration at
the microscale and here the classical amperometric method is not
feasible because of the bulkiness of sensors and restriction to only
point measurements. The most recent progress in miniaturization
of the Clark electrode21 allows one to build an electrode micro-
array22,23 which would allow monitoring gradients within
microfluidic devices in the future. However, most widely used
techniques for measurements of oxygen concentrations in
microfluidic devices are based on optical methods, which involve
photoluminescent dyes or polymer matrices doped with these
probes.24,25 The basic phenomena responsible for oxygen sensing
is dynamic quenching of luminescence by molecular oxygen.26
Most of the probes with very high quenching constants are based
on either ruthenium complexes, such as tris(bipyridyl)ruth-
enium(II)27 and Ru(II)-tris(4,7-diphenyl-1,10-phenanthroline)28–30
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or metalloporphyrins, mainly platinum(II) and palladium(II)
octaethylporphyrin (accordingly PtOEP and PdOEP)31–35 and
platinum(II) meso-tetra (pentafluorophenyl) porphyrin
(PtTFPP).32,36,37 Other probes, like Erythrosin B38 or pyrene,39
are also reported as suitable for oxygen sensing purposes.
The main advantage of the metalloporphyrin based sensors
over complexes of ruthenium based sensors is the much higher
sensitivity. This is especially important for sensing not pure
oxygen, but atmospheric air saturated cell culture media, where
the air saturation scale remains biologically relevant. Metal-
loporphyrins are non-soluble in water which is the main reason
why metalloporphyrins are usually embedded in polymers
or silicone sol–gel matrices.32,40 Consequently, ruthenium
complexes as water-soluble compounds can be added directly to
the culture media,19 which definitely would simplify the task of
sensing the dissolved oxygen concentration of the media. Such an
addition would however lead to unspecified alterations in the
metabolism of the cultured cells.10
Here we show the development of a microfluidic device that
combines chambers for cell culturing, an oxygen gradient
generator and an integrated optical sensor. This device was
designed for high compatibility with hardware available in most
laboratories. The system allows one to perform cell culturing
without directly adding an oxygen scavenger or oxygen sensing
compound to the culture media. This microfluidic system is
applied as a useful tool for biological studies where oxygen niches
are required and measurable.
Many bacteria experience fluctuating environmental changes
in their living habitats. This is caused by changes in available
nutritional factors and variation in oxygen concentrations which
the bacteria will have to adapt to in order to become a successful
colonizer.41
One such bacteria is the opportunistic pathogen Pseudo-
monas aeruginosa (P. aeruginosa) which is a recurrent and
persistent cause of lung infections in patients with the genetic
disease cystic fibrosis (CF).42 Here we use P. aeruginosa as the
model organism due to its history as a pathogen in highly
diverting oxygenated milieus. In order for this pathogen to
successfully colonize the human airways it needs to cope with
varying nutritional and oxygen levels.43 Differences in oxygen
levels are generated within the viscous mucus layer of the CF
airways and stress the bacteria to make a respiratory switch to
cope with microaerobic or especially anaerobic conditions.
Anaerobic growth of P. aeruginosa requires the presence of
alternative electron acceptors as NO3
, NO2
 or arginine in
which the bacteria renders to generate profound biofilm.44,45
Conditions of varying oxygen availability within the mucus
layers of the CF respiratory system is a metabolic challenge for
the bacteria and here we show a device that will be highly
beneficial in future studies where controlled oxygen concent-
rations are needed.
Methods
Design and fabrication
The fabricated device is comprised of five layers (Fig. 1). The
first two bottom layers (coloured red in Fig. 1A) are made of
a very low oxygen permeable material (PMMA, R€ohm GmbH
& Co. KG, Germany, oxygen permeability: 1.35 barrers46).
They contain inlets and outlets in order to connect the micro-
channel (300 mm width, 200 mm depth, 184 mm total length)
and culture chamber. The microchannel and culture chamber
were fabricated by laser ablation (48-5S Duo Lase carbon
dioxide laser, SYNRAD Inc., USA). The third layer, the
membrane, is made of 60 mm thick oxygen permeable material
(PDMS, Dow Corning Corp., USA), obtained by spincoating
(60 s, 800 rpm) uncured PDMS on an ETFE substrate
(Tefzel Fluoropolymer Film, 200LZ, DuPont de Nemours
(Luxembourg) S.A., Luxembourg) followed by curing in 70 C
for 1 h. The ETFE substrate was used here as a temporary
solid support for the membrane and was subsequently removed
after integration of the membrane into the microchip. The
fourth layer, a 150 mm thick cell culture chamber, was
fabricated by laser ablation in the low oxygen permeable ETFE
foil. The culture chamber was sealed with a glass slide covered
with the oxygen sensing dye. The sensing layer was fabricated
by doping uncured PDMS with PtOEP (Sigma-Aldrich
Denmark A S1) diluted in THF. The solution was spincoated
(60 s, 3000 rpm) to a thin film (thickness approx. 8 mm) on the
120 mm thick glass slide and cured at 70 C for 20 min. All
layers were sealed by silicone adhesive tape (ARcare 91005,
Adhesive Research, Inc., Ireland) and integrated with the base
module which contains the milled (Mini-Mill/3PRO, Minitech
Machinery Corp., USA) fluidic connectors (Fig. 1B). The
microchip was designed to fit with outer dimensions to the
microscope slide standard (76  26 mm).
Fig. 1 Schematic presentation of the different layers of the device (A)
and the fabricated microdevice (B). Here dyes are injected to visualize the
microstructures of the assembled system (blue for channel and yellow for
chamber).
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Numerical simulations
The oxygen concentration gradients were numerically simulated
in COMSOL Multiphysics 3.5a in accordance to the chamber
geometry of the designed device. For the numerical simulation,
the following conditions were assumed: the density and viscosity
of the liquid are similar to water (1000 kg m3 and 0.001 Pa s,
respectively), a maximum concentration of oxygen in water
(saturation point at standard conditions) of 0.281 mol m3,
a diffusion coefficient of oxygen in water of 1.9  109 m2 s1,
a diffusion coefficient of oxygen in PDMS of 4.1  109 m2 s1,
oxygen solubility in PDMS 0.18 cm3(STP) cm3 atm.8 The equi-
librium between oxygen in water and in PDMS can be described
by eqn (1). The rate constant of oxygen transport from water to
PDMS (k1 in eqn (1).) was set as 1.0  102 m s1 47 and the rate
constant (k2) for the reverse flux was set as 1.7  103 m s1.
Owater2 ! k1
k2
OPDMS2 (1)
The ratio of these two rate constants, under steady state
condition, is equal to the ratio of oxygen concentrations in water
and in PDMS (2). This can otherwise be expressed as a partition
coefficient (Kp) between the oxygen in PDMS and in the water
phase. This implicates the linear correlation between oxygen
concentrations in these two phases (3).
k1
k2
¼ O
PDMS
2
Owater2
¼ Kp (2)
OPDMS2 ¼
k1
k2
Owater2 (3)
The oxygen flux at the PDMS–water boundaries was modelled
according to eqn (4). The signs at rate constants depend on the
direction of oxygen diffusion.
fluxO2 ¼ k2$CPDMSO2  k1$CwaterO2 (4)
To simplify the simulation we additionally assumed a rapid
reaction of the oxygen at the interface between the membrane
and the oxygen scavenging liquid (0% oxygen concentration at
this interface as a boundary condition) (Fig. 2). This condition
can be achieved with an adequate flow of the scavenging liquid
and the addition of a catalyst.15 The liquid flow in the chamber
varied from 1 ml min1 to 500 ml min1, which corresponds to
a Peclet number for dissolved oxygen from 0.6 (diffusive trans-
port) to 290.4 (advective transport).
Photoluminescence lifetime measurements of the oxygen gradient
To form the gradient of dissolved oxygen in the growth chamber,
an oxygen scavenger (10% sodium sulfite solution with 0.1 mM
CoSO4 as catalyst, both from Sigma-Aldrich Denmark A S
1)
was pumped by a syringe pump (model 540060, TSE Systems
GmbH, Germany) through the microchannel situated beneath
the membrane with a constant flow rate of 20 ml min1, while the
growth chamber above the membrane was flushed with atmo-
spheric air saturated water with varying flow rates according to
the values used in the numerical simulations.
Photoluminescence lifetime measurements of the PtOEP based
sensor were carried out on a multi-titre plate reader (Wallac
Victor2, Perkin-Elmer Life Sciences, USA). The entire microchip
was mapped to the sectors of a 384 well plate (Fig. 3). The
excitation wavelength was 340 nm and the emission wavelength
was 640 nm.
In order to correlate the photoluminescence lifetime
measurements with the oxygen concentration, a two point cali-
bration was made. The phosphorescence decay curves for the
Fig. 2 Schematic model of the oxygen gradient generation in the microdevice.
Fig. 3 The chamber mapped to the sector of a 384-wells microplate (the
green area is the biochip, blue circles are the 384 microplate wells while
the red circles are the oxygen gradient measurement points).
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sensing layer flushed with oxygen free and air saturated water
were recorded.
For calculation of the oxygen gradient, in total 12 location
points were used. For each measurement location, the decay of
the phosphorescence curve was determined by reading the
intensities after excitation pulses at 5, 10 15, and 20 ms and then
with 10 ms intervals to 170 ms. In total, 20 points were used for the
determination of each phosphorescence decay curve. The
monoexponential model of the phosphorescence decay was
assumed according to eqn (5), where I(t) is the phosphorescence
intensity at time t, I0 is a pre-exponential factor and s is the
phosphorescence lifetime.
IðtÞ ¼ I0,e

t
T (5)
The data were fit to the model using MATLAB 2008a software
and phosphorescence lifetime was determined for every location
point. In order to convert the phosphorescence lifetime to the
dissolved oxygen concentration, a two-point calibration was
done by measuring phosphorescence lifetimes of oxygen free and
atmospheric air saturated water.
Cultivation of Pseudomonas aeruginosa, PAO1 within the
microfluidic chip
Pseudomonas aeruginosa strain PAO148 tagged with a green
fluorescent protein (GFP)49 was grown in the flow chambers of the
device. The individual chambers were either set up with water in
the channels as a control or with oxygen scavenging liquid. PAO1
biofilms were cultivated in chambers irrigated with FAB medium.
For the initial attachment experiment the media was supple-
mented with 0.3 mM glucose and for the long term cultivation
experiments with 10.0 mM sodium citrate. Several studies have
demonstrated that FAB media supplemented with sodium citrate
as the sole carbon source promote a carpet-like biofilm instead of
microcolonies and mushroom-like structures. This generates
a better possibility of quantitative comparison of the bacterial
biomass developed under different oxygen environments.50
The flow chambers were inoculated by injecting 500 ml over-
night culture diluted to an OD600 of 0.005 into each flow
chamber. This inoculum ensured that the entire culture chamber
was filled. To drive the growth of bacterial biofilm on the glass
side the chip was turned upside down without flow for 1 h after
inoculation. The media flow was subsequently started at the
flowrate of 10 ml min1 using a peristaltic pump (Watson Marlow
205S, Watson-Marlow Inc, USA), directly followed by detection
of attached bacteria by confocal laser scanning microscopy
(CLSM).
In order to illustrate biofilm development in different oxygen
environments the long term cultivation of PAO1 was performed
for 4 days using sodium citrate supplemented FAB media. All
steps were carried out at 37 C.
Microscopy and image analysis
Microscopic observations and image acquisitions were per-
formed on a Zeiss LSM 510 CLSM (Carl Zeiss, Jena, Germany).
Detectors and filter settings were set for monitoring GFP.
Confocal images of the 1 h initial attachment was taken using the
63/1.4. For each indicated time point 7 pictures were taken in
random locations of the specific oxygen saturation point. For the
long term experiments, pictures were taken at day 4 using
the 40/1.4 Plan-Neofluar oil objective. The first location for the
long term biomass measurements was chosen at an oxygen
concentration of 97%. Each consecutive measurement was per-
formed in intervals of 1 mm down the oxygen gradient (see Fig. 8
and Fig. 9 later). All images were processed using the IMARIS
software package (Bitplane AG, Z€urich, Switzerland).
For quantification of biomass the COMSTAT software was
used. COMSTAT defines biomass as a biomass volume divided
by the substratum area (mm3 mm2).50
Results
Description of the system
We have fabricated a multilayer system where we incorporated:
a PDMS immobilised oxygen sensing probe, a culture chamber,
a gas permeable membrane and a microfluidic channel for
oxygen scavenging.
The purpose of the microfluidic channel is to constantly flush
the PDMS membrane with an oxygen scavenging liquid. This
allows oxygen transport across the membrane by diffusion from
the growth chamber to the microchannel. Here the oxygen is
irreversibly consumed in a rapid chemical reaction. The oxygen
gradients generated within the chamber can be monitored by the
oxygen sensing probe.
The culture chamber was used for P. aeruginosa cultivation in
different dissolved oxygen environments.
Numerical simulations of the oxygen gradients
In order to verify the generation of dissolved oxygen gradients
within the microdevice, numerical simulations were performed.
The gradient can be observed in a horizontal as well as a vertical
plane. Since PAO1 strain forms biofilm on the glass side of the
chamber only the oxygen gradient from the top horizontal plane
was taken into consideration (Fig. 4).
The oxygen gradients vary with the media flow rate (Fig. 4)
due to changes in the ratio of advective and diffusive transport.
This ratio can be described by the Peclet number (Pe) (see eqn (6)
and Fig. 2 where L is the characteristic length, V is the velocity
the media and D is the diffusion coefficient of oxygen in water).
In the first case where the flow rate of the media is low
Fig. 4 Simulations of the oxygen saturation gradients in the growth
chamber according to the various flow rates of culture media.
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(1 ml min1, Pe ¼ 0.6), only a very short horizontal distance
within the chamber is needed to remove almost all the oxygen.
When the flow rate within the chamber is increased, the oxygen
saturation at the end of the chamber increases accordingly (2%
at 10 ml min1 (Pe ¼ 6), 43% at 50 ml min1 (Pe ¼ 29), 63% at
100 ml min1 (Pe ¼ 58) and 88% at 500 ml min1 (Pe ¼ 290) (last
not shown in Fig. 4)).
Pe ¼ L,V
D
(6)
Photoluminescence lifetime measurements of the oxygen
gradients
A two point calibration of the PDMS immobilised oxygen probe
was made to be able to calculate oxygen gradients generated
within the microfluidic device. The determined phosphorescence
lifetimes for oxygen free and atmospheric air saturated water
were: 69.7  0.4 ms and 8.2  0.1 ms, respectively. These
measurements allowed us to make a correlation between the
photoluminescence lifetime and oxygen concentration (Fig. 5).
The comparison between the numerically simulated and
measured oxygen concentration gradients were made in order to
validate both the theoretical model and the experimental data
(Fig. 6). The simulation curves were plotted as oxygen saturation
in water from the middle chamber cross-section versus the length
of the channel. For each curve, twelve measurement points were
used according to the spots marked in Fig. 3.
The measured oxygen gradients follow the data obtained by
the numerical simulations (Fig. 6). The variance coefficients
between simulated and measured oxygen concentrations were
2.2%, 5.9% and 13.5% for, accordingly, 100, 50 and 10 ml min1
media flow rates. The measured oxygen concentrations were
slightly higher than the simulated ones at high flow rates and
slightly lower at low flow rates. These differences can be
explained by the flexibility of the PDMS membrane, which was
not taken into consideration in the numerical simulations, for the
sake of model simplicity, The membrane is slightly deflecting due
to hydraulic pressure differences between the chamber and the
channel with oxygen scavenger. This affects the chamber depth
(L, Fig. 2), oxygen diffusion length and consequently the oxygen
gradient.
According to both the numerical simulations and experimental
measurements of the oxygen concentrations, we have shown that
it is possible to control the oxygen gradient by merely alternating
the media flow.
Reduced initial attachment and biofilm growth in the microdevice
To investigate the effect of the oxygen concentration on the
growth of the P. aeruginosa PAO1, we cultivated this strain in the
chip with a defined media known to support aerobic growth. We
hypothesised that the lack of an alternative electron acceptor
would affect the growth pattern of PAO1 under low oxygen
concentrations. As a reference point for comparison purposes,
we arbitrarily chose the culture chamber section with 20% of
atmospheric air saturation (microaerobic conditions).
Following one hour of attachment under this low oxygen
concentration, the attachment capacity of PAO1 to the PDMS
surface was highly reduced. As shown in Fig. 7, PAO1 prefers to
attach to the PDMS surface (shown 146.6mm  146.6mm area)
during conditions of higher air saturation. The attachment
characteristics of PAO1 was furthermore investigated by time-
lapse confocal microscopy. In a setup where the cells were
allowed 1 h of initial attachment under atmospheric air saturated
media, it was shown that the cells readily leave their attachment
site after the media is reduced in oxygen concentration (data not
shown).
Fig. 5 Phosphorescence decay curve for oxygen free and atmospheric air
saturated water (see equation 5).
Fig. 6 Comparison between simulated (dashed lines) and measured
(solid lines) oxygen concentration gradients in the culture chamber at
different media flow rates.
Fig. 7 Initial attachment of P. aeruginosa strain PAO1 at the end of
microchambers recorded after 1 h of attachment: (A) media saturated
with atmospheric air, (B) 20% of dissolved oxygen saturation.
2166 | Lab Chip, 2010, 10, 2162–2169 This journal is ª The Royal Society of Chemistry 2010
In order to quantitatively compare the effect of different
oxygen environments on PAO1 growth we used a FAB media
supplemented with sodium citrate as the sole carbon source.
We measured bacterial biomass formed after 4 days of culti-
vation in the microchambers. Under aerobic conditions
(Fig. 8A) an even distribution of carpet-like biofilm is spread
over the substratum. The drop in oxygen availability has a high
impact on the cells ability to form a stable and evenly
distributed biofilm (Fig. 8B). Fig. 9 shows clear correlation
between PAO1 biomass and the oxygen gradient generated
within the culture chamber.
Discussion
One of the main goals of our work was to design a device that
was fairly easy to fabricate and handle. In order for a device to be
a successful asset to a wide range of functional purposes in
a laboratory, the need for complicated setups and supplies
should be reduced as much as possible. In this paper we
presented a developed system which easily produces controllable
oxygen gradients within a culture chamber.
We exploit the advantages of an oxygen scavenging liquid over
methods which involve flushing the channel with oxygen–
nitrogen gaseous mixtures.19 This significantly reduces the
complexity of the setup and need of additional equipment.
Since PDMS is highly permeable, not only to O2 and N2 but
also to water vapour, the use of pressurised gases would cause
extensive drying of the culture media during long term experi-
ments. In the case of low media flow rates, this could lead to
severe changes in media osmolarity51 and introduce bubbles
within the culture chamber.52
The use of an oxygen tank in the laboratory is furthermore
a serious safety threat to the personnel, therefore any solution
which would eliminate it from the setup is highly desirable.
Furthermore we have produced a system which is cheap in
expenses for oxygen scavenging due to very small amounts of
chemicals needed.
The designed microfluidic system was integrated with a thin
film sensor which was used for the detection of dissolved oxygen
concentration gradients within the cultivation chamber. The
oxygen concentrations were monitored by photoluminescence
lifetime measurements. This specific way of monitoring oxygen
concentration is compatible with several different detection
methods as micro plate readers and fluorescence lifetime imaging
microscopes.
Since bleaching of the oxygen probe by short excitation pulses,
as used in time-resolved spectroscopy, is much lower than in the
case of excitation with continuous light, the proposed thin film
sensor can be used for long term experiments.
Prolonged exposition of the culture chamber to a strong light,
used for oxygen probe excitation, would be harmful for the
cultivated cells.53 Therefore, the short excitation pulses used in
Fig. 8 Four day old biofilm of P. aeruginosa PAO1 cultivated in FAB media supplemented with 10 mM sodium citrate under: (A) atmospheric air
saturation, (B) oxygen saturation (from left to right): 97%, 79%, 60% and 41%.
Fig. 9 Comparison of bacterial biomass developed in different oxygen
environments. The red bars represent the PAO1 biomass within the
culture microchamber under the oxygen gradient (red line). The blue bars
represent PAO1 biomass produced in the atmospheric air saturated
media.
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time-resolved spectroscopy techniques are preferable over
continuous light excitation.
Furthermore, the choice of not using dissolved oxygen probes
generate a system in which the influence of the probes on the
cells10 is completely eradicated. A significant advance over
previous approaches,19 where the authors created a system in
which oxygen probes were present within their setup, is that we
generated a highly biocompatible chip where the toxicity of the
probes is eliminated.
For the making of the thin film sensor, we chose a PDMS
matrix over the organically modified silica (ORMOSIL), which
was widely used as a sensor matrix in previous works.32 This
substitution allows one to perform biological experiments
without exposing the cultivated organism to two different envi-
ronments (a hydrophilic glass-like surface in the case of
ORMOSIL and a hydrophobic silicone rubber surface in the case
of PDMS). Having these two surfaces with radically different
properties could bias biological experimental data. This is
especially important in studies of bacterial biofilm formation,
where adherence will vary according to hydrophilicity of
a specific surface.54 However in other applications, especially for
mammalian cell cultures, the use of ORMOSIL could be
advantageous due to its chemical inertness55 and the possibility
of relatively easy surface modifications.56
Moreover, the cracking problem, reported for low molecular
mass ORMOSIL precursors40 is not present in PDMS films.
Another advantage of the PDMS based matrix is the rapid
fabrication time. The curing time for thin PDMS films is only
20 min while gelation and drying time of ORMOSIL based
matrices, reported in the literature, can be as long as 2 weeks.34
The results from photoluminescence lifetime measurements of
the dissolved oxygen gradients, which was generated within the
culture chamber, correlated well with the results obtained from
the numerical simulation. This does not only confirm the
correctness of the mathematical model of the oxygen transport in
the microfluidic system but also the reliability of time-resolved
luminescence measurements done using the proposed PtOEP film
sensor.
We consider that the discrepancies between simulated and
measured oxygen concentrations observed at some media flow
rates are due to deflection of the PDMS membrane. In order to
include this effect in the numerical simulations one would need to
incorporate one of the stress–strain models for a hyperelastic
material. In the literature one can encounter a limited number of
examples with numerical simulations of PDMS deflection.57,58
However, to our best knowledge, there is no literature data
describing how the gas permeability of PDMS is changing
according to the strain.
When the only changes in dissolved oxygen levels are due to
the chemical reaction with scavenger and diffusion–advection
transport, the numerical simulations can predict the approximate
shape of oxygen gradients within the chamber of the microchip.
However, when this is not the case, e.g. when the chamber is used
for cell culturing or when the material properties are not well
characterised, a simple mathematical model cannot precisely
predict the oxygen consumption. In such a case it will be
necessary to use an integrated sensor.
The designed system was successfully applied to support
growth of P. aeruginosa PAO1 biofilm. PAO1 responded to the
low oxygen concentration environment by a reduced number of
attached cells to the surface of the microchamber after the one
hour adherence period. This indicates that the oxygen concent-
ration within the microenvironment of the attachment site is
highly important for PAO1 to effectively bind to this surface.
The specific response to the low oxygen availability shows
that PAO1 under flow conditions seems to lack the ability to
effectively form an irreversible attachment.
In the CF lungs environment, the bacteria are living in a mucus
matrix with the presence of DNA, proteins and other factors59
which are highly diverting over the course of infection. This
is currently not possible to fully grasp in the experimental
conditions. However the most important factor in the chronically
infected CF patients is the oxygen tension.45 The presented device
makes it possible to generate such differences in oxygen levels
and is here proven to make an excellent platform for this kind of
experimental setup.
Concluding remarks
In this paper we presented a novel approach for oxygen gradient
generation within a microfluidic biochip. The system was
successfully fabricated by micromilling, laser ablation and spin-
coating techniques.
The simple layer-by-layer design allows the incorporation of
several desirable elements as the integrated gas permeable
membrane which we exploited by an oxygen scavenging liquid to
produce the desired oxygen environments. The experimental
data correlated as expected to the numerical simulations per-
formed.
Stability and biocompatibility experiments were successfully
performed over a long term biofilm culture, which proves the
system as an excellent foundation for oxygen dependent studies.
We successfully made a system that does not rely on toxic dyes
or difficult setups, but was built to be easy and safe to operate as
well as highly mobile and compatible with common used bio-
logical laboratory equipment such as microscopes and multi-titre
well plate readers.
In future CF biofilm studies, desired to be investigated in
different oxygen environments, this platform could furthermore
be used with the incorporation of other biologically important
factors, like DNA and proteins. This would be a great advance
towards mimicking the CF airways.
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Abstract 
 
A modular microfluidic airways model system that can simulate the changes in oxygen tension in 
different compartments of the cystic fibrosis airways was designed, developed and tested. The fully 
reconfigurable system comprise from modules with different functionalities: multichannel peristaltic 
pumps, bubble traps, gas exchange chip and cell culture chambers. We have successfully applied this 
system for studying the antibiotic therapy of P. aeruginosa, the bacteria mainly responsible for 
morbidity and mortality in cystic fibrosis, in different oxygen environments. Furthermore, we have 
shown the reinoculation of the bacteria form the anaerobic (CF sinuses) the aerobic compartments 
(lower respiratory tract) after the antibiotic treatment. This effect is hypothesised as the main reason 
for recurrent infections in CF patients. 
1 Introduction 
The human airways are complex multi-compartmental habitats for infectious bacteria. In healthy 
humans, the majority of the airways are essentially kept sterile as a result of highly efficient clearing 
mechanisms1. In cystic fibrosis (CF) patients, this clearing mechanism is severely impaired and 
bacterial infections inflict deteriorating health and becomes the major cause of mortality in these 
patients2, 3. 
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The human airways consist of at least three independent compartments, the conductive airways 
(the trachea, bronchi and bronchioles), the oxygen exchange compartment (alveoli), and a third, less 
recognized compartment, the paranasal sinuses (maxillary sinuses, frontal sinuses and ethmoid 
sinuses). In the first and the last compartment, the environment is essentially anaerobic4, while the 
alveoli are highly aerated. 
In healthy individuals, the conductive airways are constantly cleared by mucociliary transport of 
entrapped microorganisms5. As a result, very few bacteria will ever reach the alveoli. Bacteria that do 
evade this clearing mechanism will rapidly be cleared by the actions of the immune system. The 
sinuses also have a mucociliary clearance mechanism although not as effective as the one found in 
the conductive airways. Large concentrations of bacteria can be found widely spread throughout the 
sinuses, in particular in cases of common colds, etc6. 
Cystic fibrosis patients suffer from a defect in the cystic fibrosis transmembrane conductance 
regulator (CFTR) gene. The affected gene codes for the CFTR protein, which is a chloride channel that 
is present in the epithelial cell membrane. Reduced or absent function of the CFTR will lead to highly 
reduced secretion of chloride and accordingly water over the cell membrane7. A direct consequence 
of this defect is that the mucus layer in the conductive airways becomes very viscous and the 
mucociliary clearance mechanisms are highly impaired3, 8. This results in frequent and recurrent 
infections of the CF airways, with the risk of pneumonia. As the bacteria infect the lungs in large 
numbers, the immune system tries to eradicate the infection but with a reduced effect since the 
bacteria are embedded in mucus and more or less recalcitrant to the cellular defence9. Instead the 
lung tissue is gradually damaged by the on-going immunological exposure, eventually leading to 
massive pulmonary deficiency and death10. In the clinic, the infections can be treated with cocktails 
of antibiotics, which can reduce or sometimes eradicate the infectious agents11 
Bacterial airway infections in patients with a normal mucosa are relatively easy to treat with 
antibiotics. This is unfortunately not the case for CF patients and the myriad of infections they 
acquire during their lifetime leave each patient with a high need for recurrent antibiotic treatments. 
This is a multifactorial phenomenon and there are a lot of theories that try to explain this12-14. The 
most obvious reason for a treatment failure is the hindered diffusion of the antimicrobial agent 
through the thick and viscous mucus layer15, 16. However, according to recent findings, the main 
reason may reside in limited oxygen availability in some parts of the airways17, 18. These highly 
different oxygen environments are due to the human physiology of the airways and furthermore 
endured by the consumption from epithelial and immune cells in the local surroundings. 
As Pseudomonas aeruginosa (P. aeruginosa) infections are almost inescapable in CF patients, 
especially in older patients, this makes P. aeruginosa an important organism for studies of “oxygen” 
phenomena19. P. aeruginosa is a facultative anaerobic bacteria20 with reduced growth rate21 and 
metabolic activity18 at low oxygen levels. Antibiotics such as tobramycin, ciprofloxacin, and 
tetracycline preferentially kill the physiologically active bacteria living at high oxygen levels (aerobic 
environment), while colistin is more effective on the physiologically inactive bacteria growing in an 
anaerobic environment10, 22. 
 An antibiotic treatment can seem eventually successful, yet after a few months the very same 
bacteria that were responsible for the infection can reappear, possibly as a result of reinoculation 
from the anaerobic sinus6. In this context the sinuses could very well serve as a reservoir for “sinus” 
bacteria, which are difficult to treat with antibiotics and can cause the reinfection of otherwise 
cleared patients. 
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The now classical ways of studying CF related bacterial infections, primarily P. aeruginosa, are 
either to use animal models or to grow the bacteria in flow-cell systems.  
A number of different animals have been tried as models of chronic infections in CF patients23. 
This includes rats24-26, guinea pigs27, cats28 and rhesus monkeys29, 30. However the most important 
animal model is a mouse31-34. The use of an animal models is expensive and rise ethical concerns35, 36. 
Besides, the animal models of CF related infections are still not ideal, mainly because of immune 
response differences between man and e.g. mouse, and because the lung pathology after infection is 
very different in animals compared to humans. 
In flow-cell based systems, the bacteria are allowed to form a biofilm on a surface, as in the 
airways, and can then be monitored using a confocal microscope11, 37. However, this is not a suitable 
model for the human airways as they are subdivided into aerobic and anaerobic compartments. 
The advancement in micro- and nanofabrication and assembly, as well as better understanding 
of microfluidics, has made possible the development of devices for modelling different tissue organs.  
Thanks to these devices, the control over the environment, relations and interactions between the 
cells and tissues at microscale with high spatial and temporal resolution can be achieved38, 39. The yet 
small but fast growing number of microdevices that can mimick different and even entire organs 
have been reported. These include blood vessels40, bones41, muscles42, liver43-46, brain47, guts48, 
kidneys49, 50, endothelia51 and blood-brain barrier52. 
In the field of mimicking the human airways, Huh at al.53, 54 proposed a microfluidic device that 
can simulate injuries to the airways epithelia done by liquid plug flow. Recently, the same group 
proposed a model of the vacuoles in the lung55. In this work the phagocytosis of planktonic 
Escherichia coli cells by neutrophils on the epithelial surface was shown. 
In our previous work21 we have shown the possibility of using a poly(dimethylsiloxane) (PDMS) 
membrane and an oxygen scavenging liquid to control the oxygen gradient within cell culture 
microchambers. However, according to the authors’ best knowledge, the microfluidic model of 
different compartments of the human airways that would allow to observe the influence of the 
microenvironment of these compartments on the recurrence of CF related infections has not been 
reported previously. 
Therefore, the aim of this work was to make a model system, which simulates the three 
compartments of the airways to better understand the interplay between them. Using this artificial 
airways model, we can look into the bacterial details in the three compartments, their transmitting 
interaction, and the states of the bacterial inhabitants before, during and after antibiotic treatment. 
2 Microfluidic Airways Model 
The three sections of human airways: the conductive airways (trachea, bronchi and bronchioles), 
which are considered micro-aerobic, the highly aerobic gaseous exchange compartments (the alveoli) 
and the compartments of the paranasal sinuses, which are basically anaerobic (Fig. 1 A), are 
reproduced in this Microfluidic Airways Model (MAM). This is realized by constructing cell culture 
microchambers with different oxygen levels (Fig. 1 B). A microchamber with atmospheric air 
oxygenated media (aerobic environment) is connected by a channel to a microchamber with culture 
media saturated below the atmospheric air saturation level (micro-aerobic environment). This 
chamber is consecutively connected to a chamber with deoxygenated media (anaerobic 
environment). The connections between the chambers as well as outlets can be closed and opened 
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and the actual oxygen level in the compartments is determined by an oxygen probe. The entire 
system is actuated by peristaltic micropumps. 
 
Fig. 1 (A) The human airways system and (B) the Microfluidic Airways Model (MAM) 
3 Design 
The above model was implemented, as a modular system comprised of the following distinct 
modules: a modified previously described multichannel microfluidic peristaltic pump56, 57, a bubble 
trap, gas exchange and cell culture chambers (Fig. 2). The system allows to simultaneously cultivate 
cells in 8 chambers (3 of them facilitate aerobic environment, 2 micro-aerobic environment and 3 
anaerobic environment). 
 
Fig. 2 Modular implementation of MAM 
 
These modules can be attached to form a microfluidic platform. The detailed design of each of 
these modules and the platform is available in the electronic supplementary information (ESI) ‡. 
 
A B 
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4 Materials and methods 
4.1 Microfabrication 
The material of choice for most of the parts was polycarbonate (PC) (Nordisk Plast A/S, 
Denmark). This material exhibits low oxygen permeability (1.8 barrer58), very good mechanical and 
optical properties59 as well as being resistant to alcohols and oils, which is important for sterilization 
and microscopy. The structures in PC were obtained by micromilling (Mini-Mill/3PRO, Minitech 
Machinery Corp., USA) followed by tetrahydrofuran vapour assisted bonding (50°C, 1.5 MPa). 
PDMS inlays were fabricated by casting the silicone mixture (Sylgard 184, Dow Corning Corp., 
USA) against the milled mould. The PDMS parts were bonded to PC using silicone adhesive tape 
(ARcare® 91005, Adhesive Research, Inc., Ireland). The tape was cut into the desired shape using 
laser ablation (48-5S Duo Lase carbon dioxide laser, SYNRAD Inc., USA). 
The gaskets used for sealing the modules to the platform, as well as check valves, were 
fabricated by milling in fluoroelastomer VITON A (J-Flex Rubber Products, UK). 
4.2 Cultivation of P. aeruginosa strains 
The P. aeruginosa laboratory strain PAO1 was used for all biofilm experiments. PAO1 was 
originally isolated from a burn wound 60. PAO1 was fluorescently tagged at a neutral chromosomal 
locus with GFP or mRFP1 with miniTn7 constructs as previously described61. A FAB medium62 
supplemented with 0.3 mM glucose and 65 mM KNO3 (FAB-GN) was used for biofilm cultivation. All 
biofilms and batch cultures were grown at 37°C. PAO1 was pre-cultured overnight in Luria Bertani 
(LB) media and prepared for inoculation in FAB-GN media. The overnight culture was diluted to an 
OD600 of 0.01 and subsequently 100 l was inoculated with a Gilson P200 pipette through the 
designed inlets. In order to visualise the bacteria migration, the anaerobic culture chambers were 
inoculated with the GFP tagged strain and microaerobic and aerobic chambers were inoculated with 
the mRFP1 tagged strain. The device was left upside down for an hour without media flow. Following 
the one hour incubation period, the media flow was started at 500 l·h-1 per channel. After 48 hours 
of cultivation in the growth chambers the media was exchanged to media supplemented with 
50 g·ml-1 of the antibiotic, Ciprofloxacin (Sigma-Aldrich, Denmark A/S). 24 hours antibiotic 
treatment was followed by staining with 1 M SYTOX Blue dead cell stain (Molecular Probes, 
Invitrogen, Denmark). The chambers were left for 48 hours running on media without Ciprofloxacin. 
This was done in order to subsequently evaluate the cells ability to migrate between oxygen 
gradients. Interconnection was made between the chambers and cells were allowed to migrate for 
24 hours before analysed with confocal laser scanning microscopy.  
The interconnections between chambers were made with PVC tubing attached to PEEK 
connector plugs that were inserted into the specific chambers with different oxygen levels.    
4.3 Dissolved oxygen level control 
In order to control the dissolved oxygen levels in the cell culture media, one of the PDMS gas 
exchange module inlays was supplied with an oxygen scavenger (10% sodium sulphite solution with 
0.1 mM CoSO4 as catalyst, both from Sigma-Aldrich Denmark A/S). The second inlay was left open to 
atmospheric air. 
Determination of the oxygen levels in the cell culture chambers was achieved using  the 
phosphorescent oxygen-sensitive nanoprobe based on Platinum(II)- tetrakis-(pentafluorophenyl) 
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porphine (PtTFPP) dye63 (Luxcel Biosciences, Ireland). The oxygen levels were determined by: (i) 
phosphorescence intensity and lifetime measurements on an Axiovert 200 wide-field microscope 
(Carl Zeiss, Germany)  upgraded for phosphorescence lifetime imaging (LaVision Biotec, Germany), 
and (ii) phosphorescence lifetime measurements on a multi-label plate reader (Victor2, Perkin-Elmer 
Life Sciences, USA). The imaging experiments were performed as described in64 using pulsed 
excitation with a 390 nm LED and emission collection at 655±50 nm. Plate reader measurements 
were performed as described in63, using excitation at 340 nm and emission at 642 nm. For such 
measurements the device was inoculated with non-fluorescent P. aeruginosa laboratory strain PAO1, 
then maintained under a flow of medium, containing 0.01 mg.ml-1 of probe, for 12h and then washed 
with medium. Thus, biofilms stained with the phosphorescent probe were produced in the device, 
which can be used to monitor oxygenation and conduct biological experiments for several days. 
The correlation between the phosphorescence intensity or photoluminescence lifetime and 
dissolved oxygen concentration was determined by two-point calibration: at 0% and 100% of 
atmospheric air oxygen saturation in the culture media. The 0% atmospheric air oxygen saturation 
was obtained by supplementing the glucose containing culture media with glucose oxidase (Sigma-
Aldrich Denmark A/S). Each cell culture chamber was calibrated separately. 
4.4 Confocal microscopy and image analysis 
Confocal fluorescence images were taken with a Leica TCS SP5 microscope using a 50x/0.75W 
objective. 4 random pictures were taken from each chamber. Settings for visualization of the probes 
were: 514 nm excitation and 613-688 nm emission for mRFP1; 488 nm excitation and 517-535 nm 
emission for GFP; 458 nm excitation and 475-490 nm emission for SYTOX Blue dead stain. All 
images were processed by the Imaris 7 software package (BITPLANE AG, Zürich, Switzerland).  
5 Results 
5.1 Integration of the modular microfluidic system 
The microfluidic modules described in ESI‡ were successfully fabricated and assembled on a 
microfluidic platform (Fig. 3A). The system was integrated with 16-channel peristaltic micropump. 
The pump was actuated by two motors obtained from commercially available LEGO® Mindstorms® 
NXT 2.0 robotic kit65 (The LEGO Group, Denmark) (Fig. 3B)57. 
 
  
Fig. 3 (A) Microfluidic platform with modules and the peristaltic micropump (B).  
A B Culture chamber module 
Microfluidic modular platform 
Gas exchange module 
Bubble trap module 
Module connecting bubble traps with inlets 
Pumping units 
Pump motors 
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5.2 Determination of the dissolved oxygen level 
The correlation between the phosphorescence intensity of the P. aerugionsa biofilm stained with 
the PtTFPP nanoprobe in the aerobic and anaerobic environments was investigated in order to 
determine the oxygen removal efficiency from the culture media using the gas exchange module (Fig. 
4). The phosphorescence intensity increased approximately two-fold in anaerobic conditions as 
compared with aerobic conditions. 
 
 
 
 
 
Fig. 4 Phosphorescence intensity (top panel) and lifetime (bottom panel) images of the P. aeruginosa biofilm stained 
with the PtTFPP nanoprobe in the culture chambers with high (left) and low (right) oxygen concentration.  
 
A two step calibration curve was established by measuring The photoluminescence lifetime of 
the nanoprobe in oxygen free and atmospheric air-saturated media. The photoluminescence lifetime 
was determined to be 54.5±1.3 µs (oxygen free media) and 29.7±0.6 µs (and atmospheric air-
saturated media). Oxygen concentration in atmospheric air-saturated media was determined to be 
0.281 mM 66. The measurements were performed at room temperature. Assuming a reversible 
collisional quenching model67, the Stern-Volmer constant was determined to be  2.97 mM-1.  
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The photoluminescence lifetimes of the nanoprobe in the chambers, resembling aerobic, micro-
aerobic and anaerobic environments, were: 30.5 µs, 35.8 µs and 51.1 µs, respectively, which 
corresponds to 94.2%, 62.7% and 7.9% of atmospheric air-saturation of the culture media according 
to the two-point calibration curve. 
5.3 Cultivation of P. aeruginosa strains in different oxygen environments 
PAO1 biofilm formation was analysed after 24 hours after inoculation. In order to follow the trail 
of each specific population following each inoculation, we used differently fluorescently tagged 
versions of PAO1. The formation of the initial 24 hour biofilm under different oxygen environments in 
presence of nitrate as an alternative electron acceptor, gives rise to highly equivalent biofilm 
formations within the oxygen compartments.  
The green 3D biofilm presentation (Fig. 5A) originates from GFP tagged bacteria and was 
cultivated under the lowest oxygen saturation. The red biofilm derives from mRFP1 tagged bacteria 
and was cultivated in microaerobic (Fig. 5B) and aerobic conditions (Fig. 5C). However, under the 
tested conditions in a minimal media, the biomass within first 24 hours of growth reached highly 
equivalent magnitudes of biomass regardless of oxygen tension. Under anaerobic conditions, 
supplemented with nitrate as electron acceptor, PAO1 has in LB media shown to develop 3 fold more 
biomass68.  
In order to evaluate the efficiency of the antibiotic ciprofloxacin on PAO1 biofilms under 
conditions on differentially lowered oxygen availability in a FAB-GN media, each chamber was 
challenged with the same ciprofloxacin concentration. After 24 hours of incubation each chamber 
received media supplemented with 50 g·ml-1 of the antibiotic ciprofloxacin for a period of 24 hours. 
The treatment would present the differences in the effectiveness of the antibiotic in a developing 
PAO1 biofilm. Dead cells in the biofilms were visualized by staining each chamber with Sytox blue 
dead cell stain (Fig. 5D-F). The effect of the ciprofloxacin on the PAO1 biofilm was highly dependent 
on the oxygen environment PAO1-GFP biofilm was much more susceptible to the antibiotic 
treatment than biofilm formed under higher oxygen concentrations. The antibiotic concentration 
was chosen to eradicate the majority of cells in the establishing biofilms, though low enough to allow 
surviving cells. PAO1 had in that sense been established enough to produce a healthy biofilm and 
represent a community associated environment.    
Following the 24 h treatment with ciprofloxacin, the chambers were taken off the antibiotic 
containing media for 48 hours and connections between the different oxygen environments were 
made (Fig. 5G-I) (see connection details in the ESI). This enabled tracking of the bacteria in a novel 
way that has previously not been possible. We setup the system in a way to follow in which direction, 
if any, the surviving bacteria would move. As the ciprofloxacin treatment had been stopped the only 
difference between the chambers were the differences in oxygen concentrations. The small green 
clusters on Fig. 5H and I come from the GFP tagged bacteria. This proves that PAO1 moves from 
chambers with low oxygen tension (Fig. 5G) to microaerobic (Fig. 5H) and aerobic chambers (Fig. 5I). 
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7.9% oxygen saturation 62.7% oxygen saturation 94.2% oxygen saturation 
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Fig. 5. 3D representation of the PAO1 biofilms at different oxygen saturation in FAB-GN media (minimal media 
supplemented with nitrate). PAO1 expresses either the fluorescent protein GFP or mRFP1. A-C: 24 hours old biofilms in 
FAB-CN media. D-F: 48 h after inoculation the cells were challenged with 50 µg·ml-1 Ciprofloxacin for 24 hours and then 
stained with dead stain SYTOX Blue. G-I: Interconnected chambers of the different oxygen saturation environments.   
6 Discussion and conclusions 
In this paper we describe design, fabrication, working principle and application of a highly 
complex modular microfluidic system. Integration of different modules, bringing in such important 
functionalities as multichannel fluid control, bubble trapping, gas control - exchange and bacterial 
culturing on a microfluidic lab-on-a-chip system, has been shown to be successfully achieved. The 
modularity allows addition and removal of the different functionalities. The design permits easy 
reconfiguration and tailoring of the system to match particular needs. In case of malfunctions in a 
single module, the system benefits from its modular construction and allows uncomplicated 
exchange of the broken module without the need for fabrication of other essential parts of the 
system. This is particularly important in the field of life science microfluidic systems, in which not yet 
all of these components are suitable for mass production. Furthermore it allows quick prototype 
testing of different system configurations. 
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The microfluidic system in its present configuration enables comparison of changes between 
anatomically driven oxygen tensions in different compartments of the CF airways model, as well as 
full control and sensing of dissolved oxygen levels. By making the system compatible with common 
substrates such as microscope slides and multitier plates, it enables research staff to use standard 
laboratory equipment such as standard microscopes and multitier plate readers. 
Furthermore, the microfluidic CF airways model permits to freely reconfigure connections 
between oxygen rich and oxygen depleted regions without bringing restrictions to the researcher in 
the design of experiments. It enables to mimic some different conditions and diseases in patients 
suffering from CF, such as clogging of the ostia in recurrent sinusitis4, 69 or the development of mucus 
plugs70 in the bronchioles. These experiments were not previously possible to perform in standard in 
vitro flow-cells models for biofilm studies. In vivo models will usually not allow precise control of such 
important conditions. 
Moreover, the use of this microfluidic system, instead of a CF airways animal model, is cheaper, 
safer and easier to handle for researchers. Importantly, it furthermore does not raise any ethical 
concerns, which is the case for the use of animal models in medical research. 
We demonstrated the application of our microfluidic airway model for studying P. aeruginosa 
PAO1 under different oxygen levels in response to treatment with ciprofloxacin. We have in this way 
explicitly shown that the system is an asset in reliable and controllable biofilm evaluations for 
treatment with antibiotics at reduced oxygen concentrations. Importantly, such a system allows 
testing of very small volumes thereby minimizing the use of large amounts of expensive 
antimicrobials. PAO1 survival was shown to be highly dependent on the amount of oxygen available 
during the antimicrobial treatment. This corresponds very well with previous studies where it was 
shown that higher metabolic rate, in nitrate supplemented media under anaerobic conditions, lead 
to a lower survival rate of the bacteria71.  
We have shown that PAO1 under lowered oxygen concentrations moves towards higher oxygen 
concentrations even in nitrate supplemented media. The effect of the presence of nitrate, which 
serves as final electron acceptor for anaerobic nitrate respiration (denitrification) utilized by 
P. aeruginosa, is not favoured in the presence of oxygen and drives the migration towards the higher 
oxygen gradient.  The scenario can mimic the reinoculation of the lower respiratory tract, previously 
cleared with the antibiotic treatment from the sinuses. This effect is hypothesised as the main reason 
for recurrent infections in CF patients17.  
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1 Detailed design of the microfluidic modules 
1.1 Multichannel peristaltic micropump 
The design of the multichannel peristaltic micropump was based on a previously reported 
system1, 2 with two major changes. In the new design (Fig. 1), the previously used 
poly(dimethylsiloxane) (PDMS) inlays were exchanged with thin-walled poly(vinyl chloride) (PVC) 
tubing with 0.63 mm internal diameter (medical grade, Thoma Fluid, Reichelt Chemietechnik GmbH + 
Co, Germany). The module (Fig. 2A) was equipped with two separate micropumping units (Fig. 2B). 
Each unit (Fig. 2B) is capable of actuating up to 8 channels. In this way the capacity of each module is 
a total of 16 individual channels. The replacement of the PDMS inlays with PVC tubing allows us to 
skip the laborious process of the inlay moulding. Besides, PVC is a much more durable material than 
PDMS which makes the entire system more reliable. PVC is also known to be far more resistant to 
organic solvents and does not absorb hydrophobic agents from aqueous media as PDMS does. 
 
 
 
Fig. 1 Exploded view of the multichannel peristaltic micropump. The type of material for each fabricated part is 
indicated in parenthesis, the acronyms stands for: SS – stainless steel, Al –aluminium, PEEK – poly(ether ether ketone), 
PVC - poly(vinyl chloride), PC – polycarbonate. 
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Fig. 2 Multichannel peristaltic micropump: (A) assembled micropumping unit, (B) module with two micropumping 
units facilitating 16 channels. 
 
1.2 Bubble trap module 
The array of bubble traps was designed according to previously reported work3. The entire 
module was made in polycarbonate (PC). Each bubble trap has a volume of 56 mm3 and is equipped 
with a tapered opening on the top which serves as a vent. It can be closed or opened with the plug in 
order to release entrapped air bubbles (Fig. 3).  
 
 
 
 
 
Fig. 3 Scheme of the bubble trap module: (A) image of the module, (B) cross-section of the bubble trap. 
 
1.3 Gas exchange module 
The gas exchange module allows oxygen saturation or desaturation of a desired culture media. 
The working principle of the module was communicated in our previous report4; here described 
briefly. It is based on the oxygen diffusion through gas permeable membranes made from PDMS. The 
culture media flows through the channels fabricated in PDMS. The channels were patterned with 
groves, similar as reported in our previous work5, in order to improve mixing of the media. The 
oxygen can diffuse from the culture media through the integrated membrane to the channel filled 
with oxygen scavenging liquid. The scavenger (sodium sulphite) reacts with the available oxygen. In 
A B 
Plug 
Bubble trap 
chamber 
Inlet 
Outlet 
A B 
Module base (PC) 
Tubing stoppers (PEEK) 
the case, where the channels are filled with atmospheric air, the media is ensured to be saturated 
with oxygen. The PDMS inlays are enclosed in low gas permeability scaffold, made form PC, in order 
to separate the permeable material from the atmosphere (Fig. 4). 
 
 
 
 
 
 
 
 
Fig. 4 Scheme of the gas exchange module: (A) exploded view of the module, (B) top view for on the module layers.  
1.4 Culture chambers module 
The culture chambers were designed to implement three different oxygen saturation 
environments (Fig. 5). The module consists of 8 chambers that can be interconnected by detachable 
PVC tubing. The volume of each chamber is 4.2 µl and the area for cells attachment equals to 
12.7 mm2. Each chamber has additional tapered openings: one near its inlet and the other near its 
outlet (Fig. 6). The opening near the inlet of the chamber is used as the inoculation site. It can be 
opened and closed with a plug in the same manner as the vents in the bubble trap module. Instead 
of plugs, these openings can be equipped with fittings and tubing in order to interconnect two 
chambers with different oxygen environments.  
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Fig. 5 The scheme of the cell culture chamber module facilitating different oxygen environments. 
 
 
Fig. 6 Cell culture chamber module: (A) scheme of the module with plugs and tubing interconnecting different 
chambers (for clarity of the image, only two interconnections are shown), (B) cross-section of the fitting and tubing. 
1.5 Check microvalve 
The working principle of the designed check microvalve was based on a previous report6. An 
array of 28 check microvalves was fabricated in 1 mm thick fluoroelastomer (Fig. 7A), the same 
material that was used to fabricate the seals. The microvalves are clamped in-between the 
microfluidic modules and the platform. Each microvalve has a chamber with a 150 µm thick 
membrane (Fig. 7B). In the membrane there are two holes with Φ = 500 µm spaced 1.59 mm from 
each other (centre to centre). Such spacing is large enough to cover the holes of the microfluidic 
modules when the membrane is in a relaxed state. Membrane deflection is only possible inward the 
chamber thereby only allowing media flow in one direction (Fig. 7B). 
The purpose of the microvalve is to stop the backflow from the outlet tubing while allowing the 
user to inoculate the system using standard laboratory micropipettes. The membrane thickness, as 
well as the size and spacing between the holes, was optimised in order to get the opening pressure 
low enough enabling the use of a micropipette (typically below 1 kPa).  
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Fig. 7 Check microvalve: (A) scheme of the module with 28 independent microvalves, (B) the working principle of the 
valve 
 
 
1.6 Modular platform 
The platform was designed to comply with the microplate footprint standards7, 8. This allows the 
device to be used together with a broad range of commonly used laboratory equipment such as 
microtitre plate readers and microscopes. The platform can be equipped with up to 4 modules with a 
microscope slide size (76x26 mm). Modules can be serially interconnected by 28 independent 
channels at the long edges of a module. Additionally, each module has 8 inlets/outlets at each of the 
short edges. The platform has 28 independent inlets and the same amount of outlets (Fig. 8A). 
 
 
Fig. 8 (A) Microfluidic modular platform, (B) gasket used to seal the modules with the platform 
 
Modules are attached to the platform by screws and nuts (Fig. 9) and all the microfluidic 
connections between the modules and platform are sealed by gaskets made from fluoroelastomer 
(Fig. 8B).  
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Fig. 9 Exploded view of the microfluidic platform with modules 
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ABSTRACT 
In this paper we report a microfluidic model to simulate the bronchi of a cystic fibrosis (CF) patient. The biochip is com-
prised of two cell culture chambers separated by a membrane. On top of the membrane an alginate hydrogel is formed in or-
der to simulate the thick mucus layer spotted in a CF bronchi. In the bottom chamber a monolayer of epithelial cells are cul-
tured to simulate the bronchi tissue. By inoculating the pseudomonas aeruginosa PAO1 strain to the hydrogel layer one can 
simulate bacterial infections commonly subjected to the CF patient, and the system can be applied for the studies on antibi-
otic treatment of bacterial infection related to CF. 
 
KEYWORDS: cystic fibrosis, bronchi, model, microfluidic, microfabrication  
 
INTRODUCTION 
Here we report work towards a microfluidic system that simulates the cystic fibrosis (CF) bronchi and the impact of the 
mucus layer on the treatment of bacterial infections. The classical way of studying CF related bacterial infections, primarily 
Pseudomonas aeruginosa, is by growing them in flow-cell systems [1,2]. In these flow cells bacteria are capable of forming 
biofilm, as in the airways, and can then be monitored using confocal microscopy [3]. However, the bacteria in CF patient 
bronchi are not subjected to a constant flow of nutrients as in flow-cell based systems. Instead they embed in the mucus that 
covers the bronchi epithelia through which the nutrients and metabolites are diffusing (Figure 1A). Moreover, the content of 
the mucus highly affects bacterial attachment and biofilm growth. Consequently, the biological response for biofilm drug 
treatments can be altered by changes in the mucus [4]. 
 
THEORY 
While the human primary bronchi have a relatively large lumen diameter (order of magnitude of centimetres), the respira-
tory bronchioles are about 1 mm in diameter. Therefore, in order to be able to mimic it as closely as possible to the in vivo 
conditions, a microfluidic system is required. The presented microfluidic model of the CF bronchi consists of two chambers 
separated by a microporous membrane (Figure 1B). The membrane is the underlying support for a hydrogel, which mimics 
the mucus layer in the CF bronchi. The chamber below the membrane simulates the artery and supplies the media with nutri-
ents and transports the metabolites. These compounds are provided further to the top chamber by diffusion through the mem-
brane and hydrogel. On the bottom side of the membrane epithelial cells are cultured while on the top part of the hydrogel the 
bacteria cells are inoculated. In order to simulate antibiotic treatment, the media in the bottom channel can be supplemented 
with drugs. This supplementation can be performed in cycles, which would mimic drug dosage to CF patients. The introduc-
tion of the human sub-bronchial gland cell line (Calu-3) without the layer of hydrogel can simulate the normal bronchi while 
the same system but with the hydrogel can simulate the bronchi of CF patients. 
 
 
Figure 1: (A) Bronchi of the healthy individual and CF patient. (B) The microfluidic model of CF epithelia. 
 
EXPERIMENTAL 
The biochip (Figure 2) was fabricated in polycarbonate (PC) by micromilling (Mini-Mill/3PRO, Minitech Machinery 
Corp., USA). The PC membrane with 0.45 µm pores was inserted between the milled parts and bonded (tetrahydrofuran va-
pours assisted bonding, 3.5 MPa, 50°C). 
A B 
The hydrogel layer was formed by introduction of 0.3% sodium alginate to the top chamber and 0.1 M CaCl2 solution to 
the bottom chamber. The thickness of the hydrogel was controlled by focusing the sodium alginate stream with PBS (Figure 
3). In order to visualise the hydrogel thickness, the sodium alginate was stained with 6-aminofluorescien according to the re-
ceipt by Strand et al. [5]. 
The biochip was thoroughly washed with PBS followed by cell culture media (DMEM, 10% FBS). Calu-3 cells with a 
density of 5·105 cells/ml were seeded on the membrane in the bottom chamber. 
The inoculum (OD600 = 0.01) of  the P. aeuruginosa PAO1 strain tagged with GFP was introduced into the upper cham-
ber to mimic the bronchi infection (Figure 5). The culture was performed for 3 days in the incubator (5% CO2, 37°C) 
(HERAcell incubator, Heraeus, Germany) with perfusion of culture media through the lower chamber with flow rate 0.3 
ml·h-1. 
 
  
Figure 2: (A) The 3D model of the biochip consist from 3 layers. (B) Fabricated and bonded biochip. 
 
RESULTS AND DISCUSSION 
The obtained thickness of the hydrogel layer in the top chamber was 270±20 µm (Figure 4). The focusing buffer was ac-
tively pushing the sodium alginate through the membrane, therefore a thin (below 100 µm) layer of hydrogel was formed on 
the other side of the membrane. The vertical transport of the calcium ions through the membrane was purely diffusional. 
 
 
 
Figure 3: Numerical simulation of the formation of hydro-
gel layer in the top chamber. The thickness of the layer can be 
controlled by changing  the ratio between the sodium alginate 
and focusing buffer flow rates. 
 
Figure 4: Confocal image of the hydrogel formed 
in the biochip. Green fluorescence  represents calcium 
alginate and the gap between is the porous PC mem-
brane. The alginate was stained according to [5]. 
 
The Calu-3 cells were cultured in the bottom chamber of the system. After reaching the 70% of confluency (3rd day of 
culture) the P. aeruginosa PAO1 strain was inoculated to the upper chamber. The bacteria were allow to form biofilm in the 
hydrogel for 3 days (Figure 5A). The Calu-3 cells were stained with live/dead stain (Calcein AM/PI) in order to visualise the 
viable and necrotic epithelia (Figure 5B). 
The future application of the presented CF bronchi model lies in simulation of antibiotic treatment of CF related bacterial 
infection. The simulation of the treatment can be performed by supplementation of the culture media with drugs. The results 
expected from this should be a better understanding of the problems in the treatment of the chronically infected CF patient. 
A B 
300 µm 
  
Figure 5: (A) Confocal image of the P. aeruginosa PAO1 strain tagged with the GFP growing in the hydrogel. 
 (B) Fluorescence image of Calu-3 cells stained with live/dead stain (Calcein AM/PI) growing below the hydrogel. 
 
 
CONCLUSION 
We have successfully designed and fabricated a microfluidic biochip which can be used as a model of the CF bronchi. 
The co-culture of the Calu-3 cells and P. aeruginosa PAO1 strain using the constructed biochip was shown. By alternating 
the thickness of the hydrogel layer, the presented model can be used in the future for comparative studies of the antibiotic 
treatment of bacterial infections in normal and CF patients. This system is a significant advancement in the mimicking of the 
airways function on the chip reported earlier [6]. 
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Abstract 
Here we present our work on a microfluidic device that mimics the bronchi in people suffering 
from cystic fibrosis. To imitate the mucus of the diseased bronchi, a 200 µm thick hydrogel is formed 
in a controlled manner on the top of a microporous membrane. This membrane is also the support 
for the attachment of the epithelial cells, to mimic the bronchial tissue. In the hydrogel, P. 
aeruginosa are inoculated to recreate the scenario of bacterial infections. Compared to flow- or 
static cell culture systems our microdevice allows better imitation of the nutrient supply through the 
bronchial bio-layers.   
Eventually, nutrient driven development of bacterial growth and the viability of the epithelial 
cells are characterized by confocal laser scanning microscopy.  
 Introduction 
Cystic fibrosis 
Many severe infections in humans affect the airways. Different types of pneumonia are 
major causes of morbidity and mortality in patients with various immuno compromising conditions. 
Ineffective anti-microbial therapies often fail to remove the infecting microbes. One of the most 
severe genetic diseases affecting the human airways, is cystic fibrosis (CF) [1]. 
CF patients suffer from a genetic defect in the CFTR (Cystic Fibrosis Transmembrane 
Regulator) gene that hinders the salt transport over the cell membranes [2]. This leads to high salt 
concentration in the epithelia and low concentration in the mucus, which stops water from 
rehydrating it [3]. The mucociliary clearance mechanism is impaired and results in frequent 
infections in the CF airways with increased risk of pneumonia[4]. Since the bacteria can infect the 
airways unhindered and thrive in the CF mucus, the immune system tries to eradicate the increasing 
infecting populations. The success of the immunological battery is highly reduced since the bacteria 
are embedded in mucus and more or less recalcitrant to the attacks [5]. Instead the lung tissue is 
gradually damaged by the ongoing immunological exposure [6], eventually leading to massive 
pulmonary deficiency and death.  
Several works exist on the mimicking of the human airways using microsystems: some focused 
on the reproduction of the mechanical function of the alveoli [7-9] while others were more oriented 
on the regulation of mucin production by NCI-h292 epithelial cells [10]. Huh et al. [7] proposed 
recently a model of the vacuoles in the lung. In this work the phagocytosis of planktonic Escherichia 
coli cells by neutrophils on the epithelial surface was shown. However, according to the author’s best 
knowledge there is no system that mimics the bacterial habitats in the CF bronchi.  
 
Microfluidic model of the cystic fibrosis bronchi 
 
The classical way of studying CF related bacterial infections, primarily Pseudomonas 
aeruginosa, is by growing them in flow-cell systems [11-13] or static ones [14]. In the static cell 
systems, the amount of nutrients provided to the cells is decreasing in time as the consequence of 
bacterial consumption. Consequently, in such a system the media have to be renewed regularly but 
render a system with higher throughput than the flow-cell based systems. In the flow cells, nutrients 
and waste are constantly being exchanged to the biofilm forming bacteria. However, the bacteria in 
CF bronchi are not subjected to a constant flow of nutrients. Instead they are embedded in the 
mucus that covers the bronchi epithelia through which the nutrients and metabolites are diffusing 
(Fig. 1).  
While the human primary bronchi have relatively large lumen diameter (order of magnitude 
of centimeters), the respiratory bronchioles can be less than 1 mm in diameter [15]. Therefore, in 
order to respect this order of dimension a microfluidic system is required. 
 Fig. 1.  Bronchus of CF patient. Cross section and microfluidic dynamic of the CF bronchi 
Materials and methods  
Design 
The in vitro CF bronchus consists of a chamber divided into two parts (bottom chamber - top 
chamber) by a porous membrane (Fig. 2). The membrane is used as a solid support for a hydrogel on 
top and for attachment of epithelial cells beneath. The hydrogel mimics the mucus residing inside 
the bronchi and epithelial cells the bronchial epithelial tissue. In the top chamber, bacteria can be 
inoculated to simulate a bacterial infection taking place in chronically infected CF patients [16]. The 
bottom chamber mimics an artery, provides media with nutrients and transports the metabolites. 
These compounds are supplied further to the top chamber by diffusion through the epithelia layer, 
the membrane and the hydrogel. 
 
 
 
Fig. 2. Model for the mimicking of the CF bronchi. 
  
Procedure 
The reproduction of the in vitro bronchus model as described above followed a specific 
procedure: 
To ensure the sterility inside the device, the entire system is flushed for 30 minutes with 70% 
ethanol and then flushed for another 30 minutes with 5% hydrogen peroxide (Sigma Aldrich A/S, 
Denmark).  
The hydrogel (calcium alginate) was formed by a chemical reaction on top of the membrane. 
Following the formation of the desired thickness of alginate gel, epithelial cells were injected in the 
bottom chamber as described below in the “Epithelial cell culturing” section. Here the cells were 
allowed to adhere to the membrane as the device was orientated in an upside down position (top 
chamber down and bottom chamber up) for 24 hours. Once the bronchial cells reached a confluence 
of 90%, the 2nd day after seeding, bacteria were inoculated in the top chamber to recreate the 
scenario of a  bacterial infection. 
Fabrication of the microfluidic chip 
The main feature of the chip is the chamber in the center where the CF bronchus is mimicked. 
It has an elliptic shape with a perigee of 2 mm, an apogee of 21 mm and a thickness of 2 mm. This 
shape enables to easily remove the bubbles that may get inside the device. The membrane dividing 
the chamber is a hydrophilic poly(tetrafluoroethylene) (PTFE) membrane (BCGM 000 10, Millipore 
A/S, Denmark). It is 50 µm thick with pores of 0.4 µm diameter. Two inlets and two outlets of 0.5 mm 
in diameter are connected to the upper chamber by a 1 mm thick and 0.5 mm wide channels, the 
same for the bottom chamber (Fig. 3). The different inlets are used to inject different solutions (see 
the “Hydrogel formation” section). In practice only one of the outlets from each channel is useful but 
for a symmetry matter more of them are created. 
  
    
 
 
 
 
  
 
 
Fig. 3 Top left: Picture of the microfabricated device. Top right: Exploded view of the microfluidic chip.  
Bottom: Sketches of the top and side and view of the microfluidic chip. 
 
Each chamber with inlets, outlets and channels (except for the porous membrane) were 
fabricated by micromilling (Mini-Mill/3PRO, Minitech Machinery Corp., USA) in two polycarbonate 
(PC) slides (Nordisk Plast A/S, Denmark). Each of the slides has the dimensions of a microscope slide 
(76x26 mm) and a thickness of 3 mm.  
The polycarbonate constituting the cover of the chamber is milled down to 0.5mm in thickness 
to allow the use of high magnification microscope objectives for bacteria observation within the 
culture chamber (top chamber). Both sides of the PTFE membrane were exposed to air plasma (70 
W, 6 mbar) for 30 s to later facilitate the attachment of the epithelial cells. The PC slides were 
exposed to tetrahydrofuran (THF) vapors for 5 min. Eventually, the PTFE membrane was inserted 
between the two polycarbonate slides followed by thermal bonding (using bonding press PW 10 H, 
P/O/Weber, Germany) at 50°C with 4 MPa for 30 min.  
  
CF bronchi 
chamber 
inlets outlets 
Microporous 
membrane 
Polycarbonate slide 
Hydrogel formation 
A 100 mM CaCl2 solution (Sigma-Aldrich Denmark A/S) was used to cross-link a 0.5% (w/v) 
solution of sodium alginate (Sigma-Aldrich Denmark A/S) in order to form the calcium alginate 
hydrogel. A phosphate buffer saline (PBS) solution (Sigma-Aldrich Denmark A/S) was used as buffer. 
The hydrogel formation within the chamber was performed in the following order (Fig. 4): 
Flush of both chambers with the PBS solution for 6 min at a flow rate of 10 ml·h-1. This ensures 
that all chemicals previously used for sterilization are washed out. 
Sodium alginate is sent to the top chamber at a flow rate of 5 ml·h-1. In the bottom chamber 
PBS is kept at the same flow rate of 5 ml·h-1. This procedure is carried out for 6 min. 
The flow of PBS is stopped in the bottom chamber, instead CaCl2 is sent with a flow rate of 5 
ml·h-1 for 10 min. Calcium ions diffuse through the membrane and react with the sodium alginate to 
form the gel.  
After the 10 min, the flow of Sodium alginate is stopped and instead PBS is sent through the 
chamber at 5 ml·h-1 for 10 min. The diffusion of calcium ions strengthens the hydrogel and the 
weakly cross-linked alginate is flushed out.  
The chambers are subsequently flushed with PBS at a flow rate of 1 ml·h-1 for 30 min.  
 
 
 
Fig. 4. Process for the hydrogel formation. 
In order to determine the thickness of the hydrogel, experiments with stained sodium alginate 
were conducted. Aminofluorescein was covalently bound to the α-L-guluronate residues constituting 
the alginate by following a particular staining technique [17]. However, no stained alginate was used 
in the system while cell culturing was performed inside the device. 
Epithelial cell culturing  
Calu-3 cells were cultured in 25 cm² tissue culture flasks (Sarstedt Inc., USA) with DMEM 
(Dubelcco’s Modified Eagle Medium) supplemented with 10% (v/v) Fetal Bovine Serum (FBS) , 50 
µg·ml-1 of Gentamicin and 100 U·ml-1/100 µg·ml-1 of Penicillin/Streptomycin. The media was changed 
every second day. Once the cells reached a stage of 90% confluence they were passaged by using 
Trypsin-EDTA solution for 10 min at 37°C. 
From the harvested cells a concentration of 8·105 cells·ml-1 was prepared for seeding inside 
the chip. Cells were inoculated in the bottom chamber where the cells were allowed to adhere to the 
membrane. This was done by placing the device in an upside down position (top chamber down and 
bottom chamber up) for 24 hours in a cell culture incubator (5% CO2, 37°C) (HERAcell incubator, 
Heraeus, Germany). Eventually, the microfluidic chip remained in the incubator with a continuous 
media flow of 0.3 ml·h-1 for both chambers until a cell confluence of about 90% was obtained.  
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Calu-3 viability was checked by using a 40 nM concentration of Calcein AM to stain living cells 
and a 1.5 µM concentration of Propidium Iodide (PI) to stain dead cells. Calcein and PI respectively 
stain the cells with a green and red fluorescence as shown in Fig. 6. 
All chemicals, unless stated otherwise, were purchased from Sigma-Aldrich Denmark A/S. 
Bacteria cell culture 
The P. aeruginosa laboratory strain PAO1 was used all experiments involving bacterial 
cultivation or co-cultivation [18]. PAO1 was grown at 37°C in shaken conditions to stationary phase 
overnight in Luria Bertani (LB) media. Preparation for inoculation was done by diluting to an OD600 of 
0.01 in 0.9% NaCl. 500 µL was inoculated in the top chamber and the cells were allowed to attach 
without any media flow delivered through the system for an incubation period of 1 hour. Following 
the incubation the flow was resumed at 0.3 ml·h-1 in DMEM media with 10% of FBS without 
antibiotics. 
PAO1 was expressing the green fluorescent protein (GFP) tagged by the miniTn7 insertion 
method [19].  
 
Microscopy and data analysis 
A confocal laser scanning microscope (CLSM) (Leica TCS SP5 from Leica Microsystems A/S, 
Denmark) was used to acquire images of cells and hydrogel. Detectors and filters were set for 
monitoring Calcein-, GFP- and PI fluorescence. Images of Calu-3 cells and hydrogels were performed 
with a 10x/0.3 air objective. Bacteria were imaged with a 63x/0.70 air objective. 
In order to evaluate the thickness of the hydrogel, the pixels with an intensity higher than 25% 
of the maximum intensity value were taken into consideration. 
All the pictures were treated and analyzed by using the Imaris 7.1.1 software package 
(BITPLANE AG, Zürich, Switzerland).  
Results 
Hydrogel layer 
The thickness of the hydrogel layer depends on the time in which the Ca2+ ions are able to 
diffuse into the top chamber. The longer they can diffuse, the further up they are able to cross-link 
the alginate in the top chamber. Thus, controlling the time of diffusion allows better control of the 
gel thickness that one wants to achieve. A thickness of about 200 µm was decided for imitation of a 
mucus layer. To obtain this specific thickness, 10 min of diffusion were required during the 3rd step of 
the protocol of “Hydrogel formation” section (Fig. 4). Confocal imaging revealed that the formed 
hydrogel was 230 µm (± 20 µm) thick (Fig. 5A). 
During the optimization of the hydrogel formation, several experiments allowed the 
determination of a diffusion time range: 5 min of Ca2+ diffusion generates approximately 100 µm of 
hydrogel (Fig. 5B) whereas 15 min fills up the top chamber (Fig. 5C).   
 
 
   
Fig. 5. A. Stained hydrogel characterized by CLSM B. 100 µm thick hydrogel obtained after 5 min of Ca
2+
 diffusion. C. Top 
chamber completely filled after 15 min of Ca
2+
 diffusion. 
Co-culture of the Calu-3 epithelial cells and the P. aeruginosa PAO1 
strain 
The growth of the Calu-3 cells was successfully performed inside the microfluidic device. The 
cells reached a confluence of about 90% in 2 days (out of the 24 hours for attachment). To check the 
viability the cells were stained with Calcein AM and PI. Confocal microscopy revealed that less than 
1% of the cells were necrotic after 3 days of culturing (Fig. 6). This resembles normal Calu-3 culturing 
viability in a regular tissue culture flask (data not shown).   
 
 
Fig. 6. Epithelial layer viability after 3 days of culture. 
 
PA01 formed biofilm on top and inside the hydrogel layer (Fig. 7). Because the pores in the 
calcium alginate are much bigger (raging from tens to hundreds of microns) [20] than the size of 
bacteria, single bacteria can easily get inside and start forming microcolonies. 
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 Fig. 7. 3D visualization of PA01-GFP embedded in the calcium alginate matrix at day 5. 
Discussion 
Membrane integration 
We demonstrated a fast and easy way to integrate the PTFE porous membrane. No specific 
setup needs to be used or optimized if we compare to in situ membrane integration [21]. No 
alignment or specific treatment is required for this membrane regarding the bonding step. The 
surface treatment of polycarbonate parts using THF vapors and the thinness of the membrane (50 
µm) enable strong and durable bonding, across the membrane, between the PC slides. 
Hydrogel characterization 
In this paper, the term “hydrogel thickness” includes the membrane size, the thickness of the 
gel below and above the membrane. The thickness below the membrane is though negligible (< 2 
µm). Indeed because of due to the low diffusion coefficient of the alginate [22] a very low amount of 
it diffuses beneath the membrane and transforms into calcium alginate. Besides, the alginate does 
not affect the attachment and development of the Calu-3 cells. 
Beyond flow cell and static culture 
As mentioned in the introduction, there are two main ways to culture cells: the flow cell 
culture [11-13] and the static cell culture [14].  
However, those types of culture do not reflect the conditions in which bacteria can develop in 
niches of the human body as in the severe case of the CF airways. As explained in the microfluidic 
model of the CF bronchi, the nutrients are provided to the bacteria by diffusion across different bio-
layers from a cyclic flow (i.e. the blood stream). With this in mind, the proposed microfluidic system 
represents a significant step forward in the study of lung infections since such mimicry has not been 
reported in the literature yet. 
Eventually, this in vitro chip makes microscopy observation possible which is not the case 
when using in vivo models. Moreover, there is a very strong pressure from public societies, states, 
international organizations and from the industry to replace, reduce and refine the research 
conducted with the use of animals [23, 24]. This strategy is known as the “3 Rs” principle [25, 26]. 
Therefore, our developed microfluidic system can play an important role in the replacement of 
animal models used for medical experiments. 
30 µm 
 A new strategy for drug tests in the CF airways. 
The chip provides a new way to simulate bacterial infections in the airways. In the future, it 
can also provide a novel bio-mimetic approach regarding drug treatment. Antibiotics can be 
delivered in two different manners. One would be using a gaseous form that would be delivered to 
the upper chamber to reproduce treatment using spray antibiotics. On the other hand, a liquid form 
of the antibiotic injected in the lower chamber would simulate intravenous delivery through the 
blood stream. 
The device offers great opportunities to improve the bio-mimicry. The biological resemblance 
between the mucus and the hydrogel can be enhanced by altering the composition of additives as 
mucins and DNA [27, 28]. Such improvement will offer a better model for studying the response of a 
biofilm community to drug treatments [29]. In addition, the chip could be coupled with our previous 
system [30] to recreate the different type of dissolved oxygen conditions inside the airways. Finally 
our device brings great promises in the mimicry of other human organs where the mucus is involved, 
e.g. the gut or the stomach.  
Summary & Conclusion 
In this paper, we have demonstrated the fabrication of a robust and reliable microfluidic 
device. This device enables the setup of an in vitro microfluidic chip based mimicry of an infected 
human CF bronchus. The recreation of the scenario leading infection of the bronchi is based on a 
new approach of bacteria culture to be closer to their in vivo growth: nutrients diffuse through 
different bio-layers to feed the bacteria embedded in the mucus-like matrix. 
Inside the system, the imitation of the CF bronchus has been performed by incorporating Calu-
3 cells and hydrogel, respectively beneath and on top of a microporous membrane. The formation of 
the hydrogel has been controlled in order to mimic a mucus layer as thick as 200 µm. Calu-3 cells, 
mimicking the epithelial tissue, have been cultured for 3 days to reach 90% of confluence. A bacterial 
infection has been simulated by inoculating P. aeruginosa PA01 in the hydrogel. The formation of 
bacterial microcolonies has been observed 2 days later. Confocal microscopy allowed in vitro imaging 
of the different cells to assess of their well growth and good viability. 
For future experiments, such device can enable to simulate and observe the biofilm response 
to drug treatments taken by oral or intravenous ways. Also, mucin and DNA can be added in the 
hydrogel to study the impact of the mucus composition on the bacterial infection. 
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9 Summary and conclusions 
9.1 Key findings 
Microfluidic airways model systems that can successfully simulate the changes in oxygen tension 
in different compartments of the CF airways, have been designed, developed and presented. These 
microfluidic systems were applied for studying of infections with P. aeruginosa, the bacteria that is 
responsible for most of the recurrent CF related infections. 
The two different approaches to the system have been successfully developed. In the first 
approach (paper III and IV), a monolithic microfluidic chip was used. The layer-by-layer design 
allowed the incorporation of several desirable elements as the integrated gas permeable membrane, 
which was exploited by an oxygen scavenging liquid to produce the desired oxygen environments. 
The oxygen gradients were generated within the culture chambers and monitored by a thin film 
oxygen sensing layer. The oxygen concentrations were monitored by photoluminescence lifetime 
measurements. This specific way of monitoring oxygen concentration is compatible with several 
different detection methods as micro plate readers and fluorescence lifetime imaging microscopes. 
The designed system was applied to support growth of P. aeruginosa PAO1 biofilm. PAO1 responded 
to the low oxygen concentration environment by a reduced number of attached cells to the surface 
of the microchamber and lower rate of biomass growth. 
In the second approach (paper V), the advantages of a highly complex modular microfluidic 
system that mimics the different compartments of the CF airways have been exploited. Integration of 
different modules, bringing in such important functionalities as multichannel fluid control, bubble 
trapping, gas control - exchange and bacterial culturing on a microfluidic lab-on-a-chip system, has 
been shown to be successfully achieved. The developed passive micromixer (paper I and II) has been 
utilised to enhance the oxygen exchange in the gas control module. 
In contrast to the monolithic system described previously (paper III and IV), in the modular 
system, the culture microchambers with distinct oxygen concentration were used. In this way, it was 
possible to observe a migration of the cells between the compartments with different oxygen 
tension, as it is hypothesised to happen in the patients airways. The application of the system for 
studying P. aeruginosa PAO1 under different oxygen levels in response to treatment with 
ciprofloxacin in nitrate supplemented media has been demonstrated. It has been shown that the 
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effect of the presence of nitrate, which serves as final electron acceptor for anaerobic nitrate 
respiration utilized by P. aeruginosa, is not favoured in the presence of oxygen and drives the 
migration towards the higher oxygen gradient. It can mimic the reinoculation of the lower respiratory 
tract, previously cleared with the antibiotic treatment from the sinuses. This effect is hypothesised as 
the main reason for recurrent infections in CF patients. It has been shown that the system is an asset 
in reliable and controllable biofilm evaluations for treatment with antibiotics at reduced oxygen 
concentrations. 
A complex model of the cystic fibrosis bronchi was also developed, which allows to simulate the 
CF epithelia covered with a thick and viscous mucus layer (paper VI and VII). This system allows to co-
culturing the epithelial and bacterial cells in the environment close to that spotted in the CF bronchi 
and studying the biofilm growth under these conditions. This is a considerable advancement towards 
the development of an artificial CF bronchi model from the standard flow cell based systems and 
static co-cultures of mammalian and bacterial cells. 
9.2 Future perspectives 
The further research conducted with the described systems should try to answer the following 
question: are the bacteria in the three compartments identical phenotypically and genetically? Is 
there a detectable change in phenotype on the passage from one compartment to another? Do the 
sinuses represent a reservoir for intermittent infections of the same bacterium? Can the reinfections 
be efficiently blocked by addressing the sinus reservoirs?  
The results expected from this should be a better understanding of the problems in the 
treatment of the chronically infected CF patient. Hopefully the knowledge obtained can help in the 
prevention and treatment of these infections which severely affect the life quality of the CF patients. 
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